Ophthalmology – Lattice Degeneration

Basics

Description

Lattice degeneration is a common peripheral retinal degeneration characterized by areas of retinal thinning with abnormal vitreoretinal adhesion along their borders.

It is important because affected areas may develop:

• Atrophic retinal holes
• Retinal tears
• Rhegmatogenous retinal detachment

Despite this association, most people with lattice degeneration never develop a retinal detachment.

Epidemiology

Lattice degeneration is found in approximately 6–10% of the general population.

It is more common in:

• Myopic eyes
• Patients with a family history of retinal detachment
• Certain hereditary vitreoretinal disorders

Lattice degeneration is present in a substantial proportion of eyes that develop retinal detachment, but its presence alone does not mean that detachment will occur.

Risk Factors

Important risk factors include:

• Myopia
• Family history of lattice degeneration or retinal detachment
• Previous retinal tear or detachment in the fellow eye
• Stickler syndrome
• Wagner syndrome
• Other hereditary vitreoretinal disorders

High axial myopia is particularly associated with peripheral retinal degenerative changes.

General Prevention

There is no known method to prevent lattice degeneration from developing.

Management therefore focuses on:

• Identifying high-risk patients
• Recognizing associated retinal tears
• Educating patients about retinal detachment symptoms
• Treating significant retinal breaks when indicated

Pathophysiology

The affected peripheral retina undergoes inner retinal thinning and atrophy.

Overlying the lattice lesion, the vitreous tends to become liquefied.

At the edges of the lesion, however, the vitreous remains more firmly attached to the retina.

This combination creates:

• Thin retina within the lesion
• Liquefied vitreous over the lesion
• Strong vitreoretinal adhesion at its margins

When the posterior vitreous separates, traction at these firmly adherent borders can produce a retinal tear.

Atrophic holes can also develop directly within the thinned retina.

Etiology

The precise cause is unknown.

A genetic predisposition is likely, particularly because lattice degeneration is more common in families with:

• Retinal detachment
• High myopia
• Hereditary vitreoretinal disease

Commonly Associated Conditions

Important associations include:

• Axial myopia
• Atrophic retinal holes
• Peripheral chorioretinal atrophy
• Retinal tears
• Posterior vitreous detachment
• Stickler syndrome
• Wagner syndrome

Diagnosis

History

Most lattice degeneration is discovered incidentally during a dilated retinal examination.

Patients may be completely asymptomatic.

When symptoms occur, they are usually related to an associated posterior vitreous detachment or retinal tear rather than the lattice itself.

Important symptoms include:

• New flashes of light
• New floaters
• Sudden increase in floaters
• A curtain or shadow in the visual field
• Peripheral visual field loss
• Sudden decrease in vision

History should also include:

• Previous retinal tear
• Previous retinal detachment
• Retinal detachment in the fellow eye
• Family history of retinal detachment
• Degree of myopia

Patients who have previously undergone refractive surgery or cataract surgery may no longer appear highly myopic by refraction, so a history of preoperative myopia should specifically be obtained.

Physical Examination

A complete dilated retinal examination is required.

The vitreous should first be examined for evidence of acute posterior vitreous separation or retinal tearing.

Vitreous Pigment

Pigment cells dispersed within the anterior vitreous may suggest the presence of a retinal tear.

This finding is sometimes referred to clinically as Shafer sign or “tobacco dust.”

When present in a symptomatic patient, a careful search for a retinal break is essential.

Posterior Vitreous Detachment

The examiner should determine whether a posterior vitreous detachment is present.

Acute PVD can generate traction at the edges of lattice degeneration and increase the risk of a horseshoe retinal tear.

Appearance of Lattice Degeneration

Lattice typically appears as elongated or oval peripheral retinal lesions.

Common features include:

• Linear orientation
• Location anterior to the equator
• Orientation roughly parallel to the ora serrata
• Retinal thinning
• Pigmentary changes
• White vascular sclerosis
• Branching white lines
• Small atrophic holes

The appearance can vary considerably from one patient to another.

Retinal Thinning

The retina within the lattice area may appear:

• Thin
• Gray
• Translucent
• Atrophic

The edges may be more heavily pigmented.

White Lines

Branching white lines may cross the lesion.

These represent sclerosed retinal vessels and contribute to the classic lattice-like appearance.

Atrophic Holes

Small round holes may develop within areas of lattice degeneration.

These are usually caused by progressive thinning rather than acute vitreous traction.

Most asymptomatic atrophic holes associated with lattice do not require treatment.

Peripheral Retinal Examination

A careful peripheral examination, often with scleral depression, is important to identify:

• Horseshoe tears
• Atrophic holes
• Small retinal detachments
• Other areas of lattice

The examination should encompass the full retinal periphery.

Differential Diagnosis

Important differential diagnoses include:

• Cobblestone degeneration
• Peripheral retinoschisis
• Microcystoid degeneration
• Chorioretinal scar
• Previous retinal laser scars
• Chronic retinal detachment
• Hereditary vitreoretinal degeneration

Cobblestone Degeneration

Cobblestone or paving-stone degeneration consists of areas of peripheral chorioretinal atrophy.

Unlike lattice degeneration, it generally does not carry the same association with retinal tearing and detachment.

Peripheral Retinoschisis

Degenerative retinoschisis represents splitting of the retinal layers.

It may mimic peripheral retinal elevation or degeneration but differs from lattice in morphology and pathophysiology.

Stickler Syndrome

Stickler syndrome is an important inherited vitreoretinal disorder associated with a high risk of retinal detachment.

Features may include:

• High myopia
• Abnormal vitreous
• Lattice-like retinal degeneration
• Cataract
• Midface hypoplasia
• Small chin
• Cleft palate or bifid uvula
• Hearing abnormalities

Common genetic causes include mutations involving COL2A1 and COL11A1.

Treatment

Asymptomatic Lattice Degeneration

Most asymptomatic lattice degeneration requires observation only.

Routine prophylactic laser treatment is generally not indicated solely because lattice is present.

This remains true for many cases in which small atrophic holes are found within the lattice but there is:

• No progressive subretinal fluid
• No associated symptomatic tear
• No retinal detachment

Symptomatic Patients

A patient with new flashes or floaters requires a careful dilated retinal examination because symptoms may indicate:

• Acute PVD
• Retinal tear
• Early retinal detachment

The presence of symptoms does not automatically mean the lattice itself should be lasered.

Treatment is directed primarily at clinically significant retinal breaks or other high-risk findings.

Retinal Tears

A symptomatic tractional retinal tear is generally treated with:

• Laser retinopexy
• Cryoretinopexy in selected cases

The goal is to create a chorioretinal adhesion around the tear and reduce progression to retinal detachment.

Prophylactic Laser for Lattice

Prophylactic treatment may be considered selectively in patients with particularly high-risk circumstances, such as:

• Retinal detachment in the fellow eye
• Certain hereditary vitreoretinopathies
• High-risk retinal breaks within lattice
• Progressive subretinal fluid
• Other special circumstances determined by a retina specialist

Routine treatment of all lattice degeneration is not recommended.

Retinal Detachment

If a retinal detachment develops, treatment depends on:

• Location
• Extent
• Type of retinal break
• Lens status
• Vitreous anatomy

Possible procedures include:

• Pneumatic retinopexy
• Scleral buckle
• Pars plana vitrectomy
• Combination surgery

Referral

Referral to a retina specialist is appropriate when there is:

• Symptomatic retinal tear
• Retinal detachment
• Suspicious peripheral retinal break
• Progressive subretinal fluid
• Significant high-risk fellow-eye history
• Hereditary vitreoretinal disease

Follow-Up

Follow-up intervals depend on:

• Extent of lattice degeneration
• Presence of retinal holes
• Symptoms
• Degree of myopia
• Fellow-eye history
• Family history
• Presence of PVD

Patients with high myopia or previous retinal detachment in the fellow eye may warrant closer surveillance.

Patient Education

Patient education is extremely important.

Patients should seek urgent ophthalmic assessment if they develop:

• New flashes
• Sudden onset of multiple floaters
• A shower of black dots
• A curtain or veil in the vision
• New peripheral field loss
• Sudden decrease in visual acuity

These symptoms may represent a retinal tear or detachment.

Prognosis

The overall prognosis for isolated lattice degeneration is excellent.

Most patients never develop retinal detachment.

The absolute risk of detachment in an eye with lattice but without prior detachment in the fellow eye is relatively low.

The prognosis changes substantially if a retinal tear or detachment develops.

Complications

The major complications are:

• Atrophic retinal holes
• Horseshoe retinal tears
• Rhegmatogenous retinal detachment
• Permanent visual loss if retinal detachment involves the macula or treatment is delayed

The key clinical pearl is: lattice degeneration itself is usually observed, but new flashes, floaters, or a visual-field curtain require urgent retinal examination because these symptoms may indicate a retinal tear or detachment.

Ophthalmology – Lattice Corneal Dystrophy

Basics

Description

Lattice corneal dystrophy (LCD) is a bilateral, noninflammatory stromal corneal dystrophy characterized by deposition of amyloid within the corneal stroma. These deposits form fine, refractile, branching lines that resemble a lattice.

The major recognized forms are lattice corneal dystrophy type I and lattice corneal dystrophy type II.

Type I, also called classic lattice dystrophy or Biber-Haab-Dimmer dystrophy, is usually an autosomal dominant corneal dystrophy associated with recurrent corneal erosions and progressive visual impairment.

Type II, also called Meretoja syndrome or Finnish familial amyloidosis, produces similar corneal lattice changes but is associated with systemic amyloidosis and neuropathy.

Lattice Corneal Dystrophy Type I

Type I usually begins in the first decade of life.

Amyloid deposits develop within the central corneal stroma and gradually form branching lattice lines.

The lattice lines generally begin centrally and extend peripherally but typically do not reach the limbus.

Clinical manifestations include:

• Recurrent corneal erosions
• Eye pain
• Foreign-body sensation
• Photophobia
• Tearing
• Progressive corneal scarring
• Reduced best-corrected visual acuity

Visual impairment often becomes significant by adulthood.

Lattice Corneal Dystrophy Type II

Type II generally becomes symptomatic later, often in the third or fourth decade.

The corneal lattice lines tend to begin more peripherally and extend centrally.

Recurrent erosions may be less prominent than in type I, but reduced corneal sensation and neurotrophic epithelial problems can occur.

Unlike type I, type II is part of a systemic amyloidosis and may be associated with:

• Cranial neuropathies
• Facial weakness or drooping
• Peripheral neuropathy
• Carpal tunnel syndrome
• Autonomic dysfunction
• Cardiac arrhythmias

Epidemiology

Lattice dystrophy is among the more common stromal corneal dystrophies, although it remains relatively uncommon in the general population.

Most cases of classic LCD are inherited in an autosomal dominant fashion.

Rare autosomal recessive variants have also been described.

Risk Factors

The major risk factor is a family history of lattice corneal dystrophy.

A patient may still develop the disease without a known family history because spontaneous pathogenic variants can occur.

A family history of systemic amyloidosis is particularly important in suspected type II disease.

Genetics

Type I

Classic lattice corneal dystrophy is associated with mutations in the TGFBI gene on chromosome 5q31.

TGFBI mutations are also involved in several other stromal corneal dystrophies.

Type II

Type II is caused by mutations in the gelsolin gene on chromosome 9q34.

The mutation causes systemic amyloid deposition in addition to corneal disease.

General Prevention

There is no way to prevent the inherited disorder itself.

Genetic counseling may be useful for affected families.

Early recognition and treatment of recurrent erosions may reduce pain, infection risk, and secondary scarring.

Pathophysiology

Amyloid accumulates within the corneal stroma.

Initially, the deposits may appear as faint opacities. Over time, they develop into:

• Refractile branching lines
• Stromal haze
• Scar formation

When amyloid deposits extend toward the anterior cornea, they interfere with epithelial adhesion.

This leads to recurrent corneal erosions.

Repeated epithelial breakdown and healing eventually produce anterior stromal scarring and irregularity, which can reduce vision.

Associated Conditions

Type I

Classic LCD generally has no important systemic association.

Type II

Type II is part of systemic gelsolin amyloidosis.

Associated manifestations may include:

• Facial nerve dysfunction
• Facial drooping
• Reduced corneal sensation
• Peripheral neuropathy
• Carpal tunnel syndrome
• Autonomic dysfunction
• Orthostatic symptoms
• Cardiac rhythm abnormalities

Because of these systemic features, coordination with primary care and other specialists is important.

Diagnosis

History

Younger patients commonly present with symptoms of recurrent corneal erosion.

These include:

• Sudden foreign-body sensation
• Sharp eye pain
• Tearing
• Photophobia
• Blurred vision

Symptoms may occur in one or both eyes.

Erosions are often particularly noticeable on awakening because the eyelid may adhere to poorly attached epithelium during sleep.

Older patients may additionally report gradually worsening visual acuity from stromal scarring and irregular astigmatism.

Physical Examination

Early Disease

Slit-lamp examination may reveal:

• Fine subepithelial or anterior stromal opacities
• Faint refractile deposits near the central cornea

These findings may be subtle in young children.

Lattice Lines

As the disease progresses, characteristic:

• Thin
• Refractile
• Branching
• Interconnecting

stromal lines become visible.

They produce the classic lattice-like appearance.

In type I, these are predominantly central and usually spare the limbal region.

In type II, they may begin more peripherally and extend centrally.

Corneal Scarring

Repeated erosions can produce:

• Anterior stromal haze
• Irregular corneal surface
• Dense central scarring

This is a major cause of reduced best-corrected vision in advanced disease.

Corneal Sensation

Corneal sensation may be reduced.

This is particularly important in type II, where cranial neuropathy and neurotrophic corneal disease can lead to persistent epithelial defects.

Reduced sensation can also make corneal injuries less symptomatic despite significant epithelial damage.

Diagnostic Tests

The diagnosis is primarily clinical, based on slit-lamp findings and family history.

In atypical cases, genetic testing can be useful.

Pathological Findings

Histopathology demonstrates amyloid deposition in the corneal stroma.

Amyloid stains positively with Congo red.

Under polarized light, Congo red-stained amyloid demonstrates characteristic apple-green birefringence.

These findings confirm the amyloid nature of the deposits.

Differential Diagnosis

Important differential diagnoses include:

• Recurrent corneal erosion syndrome
• Granular corneal dystrophy
• Macular corneal dystrophy
• Amyloid corneal degeneration
• Other TGFBI-associated dystrophies

A key distinction is that lattice dystrophy shows branching amyloid lines, whereas granular dystrophy typically produces discrete crumb-like stromal deposits.

Treatment

Treatment depends on whether the main problem is:

• Recurrent erosions
• Corneal scarring
• Reduced vision
• Neurotrophic epithelial disease

Treatment of Recurrent Corneal Erosions

Lubrication

Frequent preservative-free artificial tears can reduce epithelial friction.

Lubricating ointment is particularly useful at bedtime.

Hypertonic Saline

Hypertonic sodium chloride drops or ointment may improve epithelial adhesion by reducing epithelial edema.

They are often used:

• During recurrent erosion episodes
• At bedtime for prevention

Topical Antibiotics

When an epithelial defect is present, a topical antibiotic may be used to reduce the risk of infectious keratitis.

A fluoroquinolone is commonly chosen for significant epithelial defects.

Antibiotics are not required continuously once the epithelium has healed.

Cycloplegics

Cycloplegic medication can reduce:

• Ciliary spasm
• Pain
• Photophobia

during significant acute erosion episodes.

Bandage Contact Lens

A bandage contact lens may:

• Reduce pain
• Protect regenerating epithelium
• Facilitate healing

Because an epithelial defect and contact lens together increase the risk of microbial keratitis, antibiotic prophylaxis and close follow-up are essential.

Epithelial Debridement

Loose or nonadherent epithelium may be removed to create a healthier surface for re-epithelialization.

This is particularly useful when recurrent erosions persist despite conservative treatment.

Superficial Keratectomy

For recurrent erosions with superficial scarring, superficial keratectomy may remove abnormal epithelium and anterior stromal deposits.

A diamond burr may be used to polish the underlying Bowman layer and reduce recurrence.

Phototherapeutic Keratectomy

Phototherapeutic keratectomy (PTK) can be useful when deposits and scars remain relatively superficial.

PTK can:

• Remove superficial amyloid
• Smooth the anterior corneal surface
• Improve visual acuity
• Reduce recurrent erosions

Recurrence remains possible because the genetic defect persists.

Corneal Transplantation

When stromal opacification is too deep for PTK and vision is significantly impaired, corneal transplantation may be required.

Options include:

• Deep anterior lamellar keratoplasty
• Penetrating keratoplasty

The choice depends on the depth of the disease and corneal anatomy.

Recurrence After Transplantation

Lattice dystrophy can recur in the donor cornea because abnormal amyloid-producing cells remain in the recipient tissue.

Recurrence may occur years after transplantation and can again affect visual acuity.

Delayed Epithelial Healing

Patients with lattice dystrophy may heal more slowly after corneal procedures.

Careful postoperative epithelial monitoring is therefore important.

Management of Type II

Patients with LCD II require both ophthalmic and systemic care.

Because systemic amyloidosis can cause:

• Neuropathy
• Autonomic abnormalities
• Cardiac disease

communication with primary care, neurology, and cardiology may be necessary.

Neurotrophic corneal disease may require more aggressive surface protection than classic LCD.

Referral

Referral to a corneal specialist is appropriate when:

• Erosions become frequent
• Epithelial defects persist
• Vision progressively decreases
• Corneal scarring becomes significant
• PTK or transplantation is being considered

Patients suspected of type II disease should also undergo appropriate systemic evaluation.

Follow-Up

Follow-up frequency depends on severity.

Patients with mild stable disease may be examined periodically.

More frequent review is required for:

• Active erosion
• Persistent epithelial defect
• Bandage contact lens use
• Postoperative care
• Progressive scarring

Patients who undergo transplantation require lifelong follow-up.

Monitoring After Corneal Transplantation

Patients treated with prolonged topical corticosteroids should be monitored for:

• Elevated intraocular pressure
• Steroid-induced glaucoma
• Cataract progression
• Graft rejection
• Infectious keratitis

Patient Education

Patients should understand that lattice dystrophy is:

• Genetic
• Bilateral
• Chronic
• Recurrent

There is currently no treatment that eliminates the underlying genetic defect.

However, recurrent erosions and visual impairment can usually be managed effectively.

Patients should seek urgent ophthalmic assessment for:

• Increasing pain
• Redness
• Photophobia
• Discharge
• Sudden decline in vision

because an epithelial erosion can occasionally become infected.

Prognosis

Type I

The prognosis for maintaining useful vision is generally good with proper treatment.

However, many patients eventually require procedures such as:

• PTK
• Superficial keratectomy
• Corneal transplantation

as recurrent erosions and stromal scarring accumulate.

Systemic health and lifespan are generally normal.

Type II

Patients are often less severely affected by recurrent erosions but have greater concern for systemic amyloidosis and neuropathy.

The overall prognosis therefore depends more heavily on systemic involvement.

Complications

Important complications include:

• Recurrent corneal erosions
• Corneal scarring
• Irregular astigmatism
• Reduced visual acuity
• Persistent epithelial defects
• Neurotrophic keratopathy
• Infectious keratitis
• Recurrence after corneal transplantation
• Corneal graft rejection
• Steroid-induced ocular hypertension or glaucoma

The key clinical pearl is: lattice corneal dystrophy is an inherited stromal amyloidosis characterized by refractile branching corneal lines; type I primarily causes recurrent erosions and scarring, whereas type II should prompt evaluation for systemic gelsolin amyloidosis and neuropathy.

Ophthalmology – Lagophthalmos & Lid Retraction Basics Description Lagophthalmos means incomplete eyelid closure. Lid retraction refers to abnormal elevation of the upper eyelid or depression of the lower eyelid so that sclera is visible above the superior limbus or below the inferior limbus when the patient is looking straight ahead with the brows relaxed and the head in a normal position. Both conditions can lead to exposure of the ocular surface, resulting in irritation, tearing, superficial punctate keratopathy, corneal ulceration, scarring, and, in severe cases, visual loss.

Epidemiology The incidence depends on the underlying cause. Lid retraction is the most common eyelid sign of thyroid eye disease. Lagophthalmos is also commonly encountered in: Facial nerve palsy Postoperative eyelid abnormalities Cicatricial eyelid disease Proptosis Severe ectropion

Risk Factors Risk factors depend on the cause and include: Thyroid eye disease Facial nerve palsy Previous eyelid or orbital surgery Prior trauma Chemical burns Cicatrizing conjunctival disorders Proptosis Aging-related eyelid laxity Previous aggressive blepharoplasty

General Prevention Some postoperative cases can be prevented with careful surgical technique. Important preventive measures include: Avoiding excessive skin removal during blepharoplasty Proper reconstruction of the lateral canthal tendon after canthotomy or cantholysis Appropriate use of postoperative traction sutures when indicated Avoiding excessive scarring or shortening of the eyelid lamellae Careful management of extraocular muscle surgery in thyroid eye disease Early treatment of ocular surface exposure also helps prevent corneal complications.

Pathophysiology of Lagophthalmos Normal eyelid closure depends on proper eyelid anatomy, globe position, and functioning of the orbicularis oculi muscle, which is supplied by cranial nerve VII. Lagophthalmos may occur when the eyelids are unable to cover the globe because of several mechanisms.

Proptosis If the globe protrudes excessively, normal eyelids may no longer be able to close fully over the cornea. Causes include: Thyroid eye disease Orbital tumor Retrobulbar hemorrhage Orbital inflammation Naturally shallow orbits

Anterior Lamellar Shortening The anterior eyelid lamella consists primarily of skin and orbicularis muscle. Scarring or tissue loss can shorten this layer and prevent eyelid closure. Causes include: Previous eyelid surgery Excessive blepharoplasty Trauma Herpes zoster scarring Tumor excision Burns

Posterior Lamellar Scarring The posterior lamella includes the tarsus and conjunctiva. Cicatrization can shorten the inner eyelid and restrict movement. Causes include: Ocular cicatricial pemphigoid Chemical injury Trachoma Severe conjunctival inflammation

Neurogenic Lagophthalmos The orbicularis oculi closes the eyelid and is innervated by cranial nerve VII. Facial nerve palsy can therefore cause: Poor blink Incomplete closure Lower lid laxity Ectropion Exposure keratopathy

Pathophysiology of Lid Retraction Lid retraction is present even when the eye is at rest in primary gaze. It may result from: Overactivity or fibrosis of eyelid retractors Proptosis Scarring Mechanical traction Thyroid eye disease Previous eyelid or orbital surgery Upper eyelid retraction is especially characteristic of thyroid eye disease. Lower eyelid retraction may coexist with significant ectropion.

Etiology Major causes include: Autoimmune Thyroid eye disease Ocular cicatricial pemphigoid Inflammatory or Cicatricial Postoperative scarring Trachoma Leprosy Chemical burns Neurogenic Facial nerve palsy Mechanical Proptosis Shallow orbit Eyelid tumor Scar contracture Involutional Age-related lower eyelid laxity Ectropion

Commonly Associated Conditions Important associated disorders include: Thyroid eye disease Facial nerve palsy Ectropion Previous eyelid surgery Orbital tumors Cicatrizing conjunctival disease

Diagnosis History Important questions include: When did the eyelid abnormality begin? Is it worsening? Is there tearing? Foreign-body sensation? Burning or gritty sensation? Photophobia? Eye pain? Reduced vision? Diplopia? Pain with eye movement? Previous eyelid or facial surgery? Previous trauma? History of facial herpes zoster? Chronic topical eye medication use? Chemical injury? Thyroid disease? Facial weakness? History often helps identify whether the problem is mechanical, neurologic, inflammatory, or postoperative.

Physical Examination A complete eyelid, orbital, and ocular examination is required.

Eyelid Position For lid retraction, assess the eyelids in primary gaze with: Head straight Brows relaxed No voluntary eyelid elevation Scleral show above or below the limbus supports lid retraction.

Eyelid Closure To assess lagophthalmos, the patient should be asked to gently close the eyes normally, rather than squeeze forcefully. Any residual gap between the upper and lower eyelids should be measured. Forced closure may appear normal even when spontaneous or gentle closure is inadequate.

Blink Function Observe: Frequency of spontaneous blinking Completeness of blink Orbicularis strength Bell phenomenon Reduced blink function substantially increases the risk of exposure keratopathy.

Tarsal Conjunctiva Evert the eyelids and look for: Conjunctival scarring Foreshortening Symblepharon Signs of ocular cicatricial pemphigoid

Facial Nerve Examination Look for: Facial asymmetry Poor forehead movement Weak eyelid closure Drooping mouth Reduced orbicularis strength These findings suggest cranial nerve VII dysfunction.

Proptosis Assessment Hertel exophthalmometry can quantify proptosis. Proptosis suggests an orbital cause such as: Thyroid eye disease Tumor Inflammation Hemorrhage

Ocular Motility Assess: Extraocular movements Alignment Diplopia Restriction may suggest thyroid eye disease or an orbital mass.

Pupillary Examination Check for: Relative afferent pupillary defect Abnormal pupillary responses An RAPD may indicate optic nerve involvement from severe thyroid orbitopathy or an orbital mass.

Corneal Examination This is one of the most important parts of the examination. Look for: Superficial punctate epithelial erosions Inferior exposure staining Corneal epithelial defects Ulceration Stromal thinning Scarring Infection Fluorescein staining helps define the extent of exposure damage.

Anterior Segment Examination Also assess for: Iris atrophy Uveitis Corneal edema Secondary inflammation

Fundus Examination Fundoscopy is important when orbital disease is suspected. Possible findings include: Choroidal folds Optic disc edema Optic atrophy These findings may indicate orbital compression or mass effect.

Diagnostic Tests and Interpretation Thyroid Testing If thyroid eye disease is suspected, testing may include: TSH Free T4 T3 Thyroid-stimulating immunoglobulins or related thyroid antibodies

Conjunctival Biopsy If ocular cicatricial pemphigoid is suspected, conjunctival biopsy may be performed for direct immunofluorescence. Typical findings may include deposition of immunoglobulins and complement along the basement membrane zone.

Orbital Imaging CT or MRI of the orbits may be indicated when evaluating for: Thyroid eye disease Orbital mass Proptosis Extraocular muscle enlargement Orbital inflammation In thyroid eye disease, enlargement of extraocular muscle bellies with relative tendon sparing may be seen.

Brain and Facial Nerve Imaging MRI or other neurologic imaging may be required when investigating unexplained facial nerve palsy. The exact imaging depends on the suspected location and cause of the lesion.

Visual Field Testing Visual fields may be useful when optic neuropathy is suspected. Defects can occur in: Severe thyroid eye disease Orbital tumors Compressive lesions

Color Vision Reduced color discrimination may be an early sign of compressive optic neuropathy.

External Photography Clinical photographs are useful for: Documenting eyelid position Monitoring progression Comparing with old photographs Distinguishing acquired disease from a longstanding normal variant

Differential Diagnosis The differential depends on the suspected mechanism. Important possibilities include: Thyroid eye disease Orbital tumor Shallow orbits Facial nerve palsy Cicatricial eyelid disease Postoperative scarring Ectropion Ocular cicatricial pemphigoid Chemical injury Apparent lower lid retraction can occasionally result from chronic abnormal head posture rather than true eyelid disease.

Treatment Treatment has two major goals: Protect the cornea Correct the underlying eyelid or orbital abnormality

Observation If the patient is asymptomatic and the cornea remains healthy, observation may be appropriate. Periodic examination is still required because exposure can worsen.

Lubrication First-line therapy for exposure usually includes: Frequent preservative-free artificial tears Lubricating gels Ointment at bedtime More severe exposure requires more frequent lubrication.

Nighttime Protection Patients with nocturnal lagophthalmos may benefit from: Taping the eyelids closed Moisture chamber goggles Protective eye shields The lids should be closed carefully without exerting pressure on the globe.

Environmental Measures Patients should avoid excessive ocular surface drying. Helpful measures include: Directing fans away from the face Avoiding strong air-conditioning drafts Using a room humidifier Avoiding unnecessary prolonged exposure to dry environments

Treatment of Associated Conditions Other ocular surface problems should also be treated, including: Blepharitis Allergic conjunctivitis Dry eye Meibomian gland dysfunction Underlying systemic conditions such as thyroid eye disease or ocular cicatricial pemphigoid require specific treatment.

Surgical Treatment Surgery is considered when conservative therapy does not adequately protect the cornea or when eyelid malposition is significant. The procedure depends on the mechanism.

Tarsorrhaphy A temporary or permanent tarsorrhaphy partially joins the upper and lower eyelids. It can be very effective for severe exposure. It may be used in: Facial nerve palsy Neurotrophic cornea Severe lagophthalmos Persistent epithelial defects

Upper Eyelid Retraction Surgery Upper eyelid retractors may be recessed. Structures that may be weakened include: Müller muscle Levator palpebrae superioris The procedure may be performed through a skin or conjunctival approach.

Upper Eyelid Weight Implant For facial nerve palsy, a gold or platinum weight can be implanted into the upper eyelid. Gravity helps bring the lid downward when the patient attempts to close the eye. Platinum weights are often thinner for a given weight than gold implants.

Eyelid Springs Mechanical eyelid springs may occasionally be used in selected facial paralysis cases.

Lower Eyelid Retraction Surgery Options include: Lower lid retractor recession Lateral canthal tightening Spacer graft placement Midface elevation in selected cases Spacer materials may include: Buccal mucosa Acellular dermal matrix Other graft tissues

Skin Grafting Anterior lamellar deficiency may require a full-thickness skin graft. This is particularly relevant after: Excessive blepharoplasty Trauma Tumor removal Cicatricial shortening

Ectropion Repair Paralytic or involutional lower lid ectropion may require: Horizontal shortening Lateral tarsal strip Canthoplasty Improving lower eyelid position helps restore the tear reservoir and protect the cornea.

Management of Facial Nerve Palsy The urgency of surgical intervention depends partly on whether facial nerve recovery is expected. If recovery is likely, temporary measures may be preferred. If permanent weakness is expected, definitive correction of: Lagophthalmos Upper lid retraction Lower lid ectropion may be necessary.

Follow-Up Follow-up depends primarily on the severity of corneal exposure. Severe disease may require: Daily review Very frequent outpatient monitoring Occasionally inpatient management Mild stable disease may only require periodic or annual review.

Referral Depending on the cause, appropriate specialists may include: Oculoplastic surgeon Corneal specialist Endocrinologist Primary care physician Neurologist ENT specialist Neurosurgeon

Patient Education Patients should understand that the main risk is corneal exposure. They should seek urgent review for: Increasing pain Sudden decrease in vision Increased redness Severe photophobia Corneal opacity Increasing discharge Regular lubrication and nighttime protection should be emphasized when recommended.

Prognosis The prognosis depends on: Underlying cause Severity of eyelid dysfunction Degree of corneal exposure Corneal sensation Response to treatment Mild cases may remain stable with lubrication alone. Severe untreated exposure can progress to: Persistent epithelial defect Infectious keratitis Corneal ulceration Thinning Perforation Permanent visual loss

Complications Important complications include: Exposure keratopathy Corneal abrasion Corneal ulceration Infectious keratitis Corneal scarring Corneal perforation Visual loss Chronic tearing Cosmetic disfigurement The key clinical pearl is: lagophthalmos is diagnosed by incomplete gentle eyelid closure, while lid retraction is diagnosed by scleral show in primary gaze; in both conditions, the immediate priority is protection of the corneal surface.

Ophthalmology – Lacrimal Gland Tumors

Basics

Description

Lacrimal gland tumors and masses comprise a broad group of disorders involving the lacrimal gland in the superotemporal orbit. They may be:

• Epithelial or nonepithelial
• Benign or malignant
• Inflammatory or neoplastic
• Primary or metastatic

Only a minority of orbital lesions arise from the lacrimal gland, and most lacrimal gland enlargements are nonepithelial, particularly inflammatory or lymphoid disorders.

Important categories include:

• Inflammatory dacryoadenitis
• Idiopathic orbital inflammatory disease
• Sarcoidosis
• Lymphoid tumors
• Dacryops
• Pleomorphic adenoma
• Adenoid cystic carcinoma
• Other epithelial malignancies
• Metastatic disease

The clinical behavior varies widely, so the tempo of growth, presence of pain, globe displacement, imaging characteristics, and bone involvement are particularly important.

Epidemiology

Approximately 10% of orbital lesions involve the lacrimal gland.

Most lacrimal gland lesions are nonepithelial. Important nonepithelial causes include:

• Inflammatory disease
• Lymphoma
• Reactive lymphoid hyperplasia
• Sarcoidosis

Among epithelial tumors, benign lesions include pleomorphic adenoma and ductal cysts such as dacryops, while adenoid cystic carcinoma is one of the most important malignant epithelial tumors.

Adenoid Cystic Carcinoma

Adenoid cystic carcinoma can occur at almost any age but most often presents in adulthood.

It is notable for:

• Relatively rapid progression
• Pain
• Bone destruction
• Perineural invasion
• Local recurrence
• Potential intracranial and systemic spread

Pain is an especially important warning sign because perineural invasion is characteristic.

Dacryops

A dacryops is a ductal cyst involving the lacrimal gland, often the palpebral lobe.

It is usually:

• Benign
• Slowly growing
• Painless
• Occasionally visible beneath the superior temporal conjunctiva

Many require no treatment unless they become symptomatic or enlarge.

Lymphoid Lesions

Lymphoid disease of the lacrimal gland includes:

• Reactive lymphoid hyperplasia
• Atypical lymphoid hyperplasia
• Non-Hodgkin lymphoma

Orbital lymphoma is more common in older adults and often presents as a painless, slowly enlarging lacrimal gland mass.

Idiopathic Orbital Inflammation

Idiopathic orbital inflammatory disease may involve the lacrimal gland and present as inflammatory dacryoadenitis.

It commonly produces:

• Acute pain
• Swelling of the lateral upper eyelid
• Tenderness
• Conjunctival injection
• Diplopia
• Proptosis

A rapid response to corticosteroids may occur, but corticosteroid responsiveness does not by itself establish the diagnosis.

Sarcoidosis

The lacrimal gland is one of the most commonly affected orbital structures in sarcoidosis.

Lacrimal gland involvement may be:

• Bilateral
• Painless or mildly uncomfortable
• Associated with dry eye
• Associated with systemic pulmonary, skin, or lymph node disease

Sarcoidosis is particularly important in younger and middle-aged adults.

Risk Factors

Risk factors depend on the underlying pathology.

Malignant Epithelial Tumors

Important concerns include:

• Previous incomplete excision of a lacrimal gland epithelial tumor
• Recurrent pleomorphic adenoma
• Longstanding lesion with recent acceleration in growth

Incomplete excision of pleomorphic adenoma can lead to recurrence and, rarely, malignant transformation.

Lymphoma

Sjögren syndrome and other chronic autoimmune conditions may increase the risk of ocular adnexal lymphoma.

Inflammatory Disease

Immune-mediated disease and systemic inflammatory disorders may predispose to lacrimal gland inflammation.

Genetics

Genetic abnormalities vary according to tumor type.

Certain lymphomas have characteristic chromosomal translocations and molecular abnormalities.

Sarcoidosis has complex genetic susceptibility with HLA and other immune-related associations.

Most benign epithelial lacrimal gland tumors do not have a simple inherited pattern.

General Prevention

There is no reliable strategy to prevent most lacrimal gland tumors.

The most important preventive principle is appropriate management of a suspected pleomorphic adenoma, because incomplete biopsy or piecemeal excision can increase the risk of recurrence.

Etiology

Epithelial Lesions

Important epithelial lesions include:

• Dacryops
• Pleomorphic adenoma
• Adenoid cystic carcinoma
• Carcinoma ex pleomorphic adenoma
• Mucoepidermoid carcinoma
• Other adenocarcinomas

Nonepithelial Lesions

These include:

• Idiopathic inflammatory dacryoadenitis
• Lymphoma
• Reactive lymphoid hyperplasia
• Sarcoidosis
• Leukemia
• Granulomatosis with polyangiitis
• Metastatic disease
• Plasmacytoma
• Dermoid lesions
• Infectious dacryoadenitis

Commonly Associated Conditions

Lymphoma

A pink, fleshy salmon-patch conjunctival lesion may accompany ocular adnexal lymphoma.

Sjögren syndrome is associated with increased lymphoma risk.

Sarcoidosis

Associated systemic findings include:

• Pulmonary disease
• Bilateral hilar lymphadenopathy
• Uveitis
• Skin disease
• Parotid enlargement
• Cranial neuropathies

Heerfordt Syndrome

This may include:

• Parotid enlargement
• Uveitis
• Facial nerve palsy
• Fever

Löfgren Syndrome

This includes:

• Erythema nodosum
• Bilateral hilar lymphadenopathy
• Arthritis or arthralgia

Diagnosis

History

The history should focus on:

• Duration of the mass
• Rate of enlargement
• Pain
• Diplopia
• Visual decline
• Previous orbital surgery
• Previous lacrimal gland biopsy
• Previous malignancy
• Autoimmune disease
• Constitutional symptoms
• Respiratory symptoms

The pattern of symptoms often provides clues to the underlying pathology.

Clinical Patterns

Benign Epithelial Tumor

A benign epithelial tumor such as pleomorphic adenoma typically causes:

• Slow, painless progression
• Proptosis
• Inferonasal globe displacement
• Upper eyelid fullness

The course may extend over months to years.

Malignant Epithelial Tumor

Features concerning for malignancy include:

• Relatively rapid growth
• Significant pain
• Sensory disturbance
• Diplopia
• Ptosis
• Bone destruction
• Perineural symptoms
• Reduced vision

Adenoid cystic carcinoma is especially associated with pain from perineural invasion.

Inflammatory Dacryoadenitis

Inflammatory disease tends to present more abruptly with:

• Pain
• Tender upper eyelid swelling
• Redness
• Conjunctival chemosis
• Tearing
• Diplopia

The lateral upper eyelid may develop an S-shaped contour.

Lymphoma

Lymphoma often presents as:

• Painless
• Slowly progressive
• Firm lacrimal gland enlargement
• Proptosis
• Globe displacement

Bilateral disease is possible.

Physical Examination

A complete ophthalmic and orbital examination should include:

• Visual acuity
• Pupillary examination
• Color vision
• Visual fields
• Intraocular pressure
• Extraocular movements
• Eyelid position
• Proptosis measurement
• Cranial nerve examination
• Slit-lamp examination
• Dilated fundus examination

Globe Displacement

Lacrimal gland masses characteristically displace the globe inferonasally because the gland lies in the superotemporal orbit.

The degree and direction of displacement provide useful localization information.

Optic Nerve Assessment

Large or posterior lesions can compress the optic nerve.

Signs of compressive optic neuropathy include:

• Reduced visual acuity
• Dyschromatopsia
• Relative afferent pupillary defect
• Visual field loss
• Optic disc edema or pallor

Any evidence of optic nerve compromise requires urgent evaluation.

Anterior Segment Findings

Depending on the underlying disorder, slit-lamp examination may demonstrate:

• Conjunctival masses
• Conjunctival inflammation
• Episcleritis
• Scleritis
• Dry eye
• Keratic precipitates
• Anterior chamber cells and flare
• Synechiae

These findings may point toward inflammatory or systemic disease such as sarcoidosis.

Posterior Segment Findings

Possible findings include:

• Retinal vasculitis
• Peripheral vascular sheathing
• Intermediate uveitis
• Optic disc swelling

These are more suggestive of systemic inflammatory conditions than isolated epithelial tumors.

Systemic Examination

When systemic inflammatory or malignant disease is suspected, examination should look for:

• Lymphadenopathy
• Skin lesions
• Erythema nodosum
• Arthritis
• Hepatosplenomegaly
• Pulmonary signs

Diagnostic Tests and Interpretation

Laboratory Evaluation

Laboratory testing should be guided by the clinical differential rather than performed indiscriminately.

Possible tests include:

• CBC with differential
• ESR and CRP
• Serum protein electrophoresis
• ACE and other sarcoid-directed testing
• ANCA when granulomatosis with polyangiitis is suspected
• ANA when autoimmune disease is suspected
• Syphilis serology
• Tuberculosis testing

Modern sarcoidosis workup generally relies more heavily on the overall clinical picture and tissue confirmation than on ACE alone.

Orbital Imaging

CT

Orbital CT is useful for evaluating:

• Tumor location
• Bone remodeling
• Bone erosion or destruction
• Calcification
• Extension into adjacent structures

Bone destruction strongly increases concern for malignancy or aggressive inflammation.

MRI

MRI provides superior soft-tissue characterization and is useful for assessing:

• Perineural spread
• Intracranial extension
• Cavernous sinus involvement
• Orbital apex extension
• Relationship to surrounding muscles and nerves

Contrast-enhanced MRI is especially valuable when malignant disease is suspected.

Chest Imaging

Chest radiography or CT may be indicated if considering:

• Sarcoidosis
• Tuberculosis
• Metastatic disease
• Primary thoracic malignancy

Biopsy Principles

Biopsy strategy depends strongly on the suspected diagnosis.

Important Principle – Pleomorphic Adenoma

A lesion strongly suspected to be a pleomorphic adenoma should generally not undergo incisional biopsy, because violating the pseudocapsule can seed tumor cells and increase the risk of recurrence.

The preferred approach is complete intact excision when technically appropriate.

Inflammatory or Lymphoid Lesions

Biopsy is often appropriate when:

• The diagnosis is uncertain
• Lymphoma is suspected
• The lesion is atypical
• Steroid response is incomplete
• The disease recurs
• Malignancy is possible

Preferred Biopsy Site

When lacrimal gland biopsy is required, the orbital lobe is often preferred when feasible to reduce damage to the ductules of the palpebral lobe and thereby reduce postoperative dry eye.

Sarcoidosis Biopsy

Tissue may be obtained from:

• Lacrimal gland
• Conjunctiva
• Skin lesion
• Lymph node
• Pulmonary tissue

Histology demonstrates noncaseating granulomas, but infectious causes of granulomatous inflammation must be excluded.

Special stains and microbiologic testing may be necessary for:

• Mycobacteria
• Fungal organisms

Pathological Findings

Adenoid Cystic Carcinoma

Histologic patterns include:

• Cribriform
• Tubular
• Basaloid
• Solid
• Other mixed patterns

Perineural invasion is a characteristic and clinically important feature.

Pleomorphic Adenoma

Pleomorphic adenoma contains a mixture of:

• Epithelial elements
• Myoepithelial elements
• Myxoid or chondroid stroma

Sarcoidosis

Typical pathology shows noncaseating granulomas after exclusion of infection.

Idiopathic Orbital Inflammation

Pathology may show a mixed inflammatory infiltrate with:

• Lymphocytes
• Plasma cells
• Macrophages
• Variable eosinophils
• Fibrosis
• Tissue edema

Differential Diagnosis

Important differential diagnoses include:

• Pleomorphic adenoma
• Adenoid cystic carcinoma
• Lymphoma
• Reactive lymphoid hyperplasia
• Idiopathic orbital inflammation
• Sarcoidosis
• Granulomatosis with polyangiitis
• Metastatic tumor
• Leukemia
• Dermoid cyst
• Prolapsed orbital fat
• Infectious dacryoadenitis
• Perilacrimal orbital tumors

Prolapsed orbital fat can mimic lacrimal gland enlargement, particularly in older adults.

Treatment

Treatment depends entirely on the underlying diagnosis.

Pleomorphic Adenoma

The preferred treatment is complete surgical excision with the capsule intact.

Incomplete excision should be avoided because it increases the risk of:

• Recurrence
• Multifocal seeding
• Malignant transformation

Dacryops

Asymptomatic lesions may be observed.

Symptomatic or enlarging lesions may undergo:

• Marsupialization
• Complete excision

depending on location and anatomy.

Adenoid Cystic Carcinoma

Management usually requires multidisciplinary orbital oncology care.

Treatment may involve combinations of:

• Complete surgical resection when feasible
• Radiation therapy
• Systemic therapy in selected cases

The historical use of routine orbital exenteration has evolved, and modern treatment is individualized according to tumor extent, margins, perineural spread, and available eye-sparing oncologic approaches.

Lymphoma

Treatment begins with tissue diagnosis and staging.

Management may include:

• Local radiation for localized disease
• Systemic immunotherapy
• Chemotherapy
• Combined approaches

Treatment depends on lymphoma subtype and systemic involvement.

Sarcoidosis

Treatment depends on severity.

Possible approaches include:

• Observation for mild disease
• Systemic corticosteroids
• Steroid-sparing immunomodulatory therapy

Surgery is generally limited to diagnostic biopsy or selected cases requiring decompression.

Idiopathic Orbital Inflammation

Corticosteroids are commonly used when the diagnosis is sufficiently secure.

A prompt clinical response is expected in many cases.

However, lack of response, recurrence, or atypical imaging should prompt reconsideration of the diagnosis and often biopsy.

Steroid-resistant disease may require:

• Immunomodulatory therapy
• Radiation therapy
• Alternative diagnosis workup

Infectious Dacryoadenitis

Infectious causes require organism-directed treatment.

Bacterial disease may require:

• Systemic antibiotics
• Drainage if abscess develops

Steroids should not be given as stand-alone treatment if infection remains possible.

Referral

Referral may include:

• Oculoplastic/orbital surgeon
• Ocular oncologist
• Hematology/oncology
• Rheumatology
• Pulmonology
• Neurology or neurosurgery
• Infectious disease

depending on the suspected pathology.

Inpatient Considerations

Admission may be required for:

• Compressive optic neuropathy
• Rapidly progressive orbital inflammation
• Severe infection
• Intravenous corticosteroid treatment
• Orbital surgery
• Significant neurologic extension

Optic nerve dysfunction from a lacrimal gland mass requires urgent management.

Follow-Up

Follow-up depends on etiology.

Inflammatory disease may require close review during active treatment, often within days to weeks.

Malignant tumors require long-term surveillance for:

• Local recurrence
• Perineural spread
• Distant metastasis

Benign lesions that have been completely excised generally require less intensive monitoring but still need assessment for recurrence when clinically indicated.

Monitoring During Corticosteroid Therapy

Patients receiving prolonged corticosteroids should be monitored for:

• Elevated IOP
• Cataract
• Hyperglycemia
• Hypertension
• Bone loss
• Other systemic adverse effects

Coordination with primary care or relevant medical specialists is important.

Prognosis

Prognosis varies dramatically with the underlying diagnosis.

Benign Lesions

Completely excised benign epithelial tumors generally have an excellent prognosis.

Inflammatory Disease

Idiopathic inflammation and sarcoidosis often respond well to treatment but can recur.

Lymphoma

Prognosis depends on histologic subtype and systemic stage.

Adenoid Cystic Carcinoma

Adenoid cystic carcinoma has a more guarded prognosis because of:

• Perineural invasion
• Local recurrence
• Intracranial extension
• Distant metastasis

Long-term surveillance is essential.

Complications

Potential complications include:

• Proptosis
• Diplopia
• Ptosis
• Exposure keratopathy
• Dry eye after lacrimal gland surgery
• Optic neuropathy
• Vision loss
• Tumor recurrence
• Intracranial extension
• Metastatic disease

The key clinical pearl is: a slowly enlarging painless superotemporal orbital mass suggests a benign epithelial or lymphoid lesion, whereas rapid growth, pain, sensory symptoms, bone destruction, or perineural involvement should raise strong suspicion for lacrimal gland malignancy, particularly adenoid cystic carcinoma.

Ophthalmology – Keratoconus

Basics

Description

Keratoconus is a progressive, noninflammatory disorder of the cornea characterized by corneal thinning, steepening, and protrusion. As the cornea becomes increasingly irregular, it develops a cone-like shape.

The resulting optical distortion commonly causes:

• Progressive astigmatism
• Increasing myopia
• Reduced best spectacle-corrected visual acuity
• Glare and visual distortion
• Monocular diplopia
• Difficulty tolerating contact lenses
• Corneal scarring in advanced disease

The condition is usually bilateral, although one eye may be much more severely affected.

Epidemiology

Keratoconus often becomes clinically apparent during puberty or early adulthood.

The prevalence varies considerably between populations and studies, but it is generally considered an uncommon-to-moderately common corneal ectatic disorder.

Progression is usually faster in younger patients and may slow with increasing age.

Risk Factors

Important risk factors include:

• Eye rubbing
• Chronic ocular allergy
• Atopy
• Family history of keratoconus
• Repetitive mechanical pressure on the eye
• Floppy eyelid syndrome
• Sleep apnea

A first-degree relative with keratoconus increases the likelihood of developing the disease.

Genetics

Keratoconus has a genetic component, but there is no single inheritance pattern in most patients.

Familial clustering occurs, and some families show patterns compatible with incomplete autosomal dominant inheritance.

The disease is likely multifactorial, involving both genetic susceptibility and environmental or mechanical influences.

General Prevention

The most important modifiable measure is to avoid eye rubbing.

Patients with ocular allergy should receive appropriate treatment to reduce itching and the urge to rub.

Avoiding direct pressure on the cornea during sleep may also be reasonable in susceptible individuals.

Pathophysiology

Keratoconus produces progressive biomechanical weakening of the cornea.

The anterior and posterior corneal surfaces become increasingly irregular, causing:

• Irregular astigmatism
• Higher-order aberrations
• Reduced image quality

As the cornea thins and protrudes, the cone may become more pronounced.

Breaks in Bowman layer can lead to fibrosis and stromal scarring.

A rupture in Descemet membrane can allow aqueous humor to enter the corneal stroma, producing sudden severe edema known as acute corneal hydrops.

Etiology

The exact cause remains incompletely understood.

Likely contributing factors include:

• Genetic predisposition
• Abnormal corneal biomechanics
• Oxidative stress
• Enzymatic alterations within the corneal stroma
• Chronic mechanical trauma from eye rubbing

Commonly Associated Conditions

Keratoconus has been associated with:

• Floppy eyelid syndrome
• Obstructive sleep apnea
• Atopy
• Allergic conjunctivitis
• Down syndrome
• Leber congenital amaurosis
• Aniridia
• Retinopathy of prematurity
• Ehlers-Danlos syndrome
• Marfan syndrome
• Osteogenesis imperfecta

Some corneal dystrophies may also coexist.

Diagnosis

History

Patients may complain of:

• Gradually worsening vision
• Increasing astigmatism
• Frequent changes in glasses prescription
• Glare
• Halos
• Ghost images
• Monocular diplopia
• Reduced contrast sensitivity
• Difficulty driving at night
• Contact lens intolerance

The disease is commonly asymmetric.

A history of habitual eye rubbing should be specifically sought.

Some patients report pressing or rubbing one eye more than the other or sleeping predominantly on the more affected side.

Physical Examination

Refraction

Refraction may show:

• Increasing myopia
• Increasing astigmatism
• Irregular astigmatism
• Fluctuating refractive measurements

Vision may eventually become poorly correctable with spectacles.

Retinoscopy

A classic finding is a scissoring reflex due to irregular corneal curvature.

The red reflex may appear distorted or irregular.

External Signs

Advanced disease may produce visible corneal protrusion.

Munson Sign

When the patient looks downward, the cone-shaped cornea may indent the lower eyelid in a V-shaped configuration.

This is known as Munson sign.

It is generally a late finding.

Slit-Lamp Findings

Important signs include:

Fleischer Ring

An iron deposition ring around the base of the cone.

It is located in the basal epithelium and may be partial or complete.

Vogt Striae

Fine vertical lines in the deep stroma and Descemet membrane.

They often disappear temporarily when gentle external pressure is applied to the globe.

Corneal Thinning

The cornea is thinnest near the apex of the cone, which is often displaced inferiorly or inferotemporally.

Corneal Scarring

Progressive stromal stress and breaks in Bowman layer may produce:

• Apical haze
• Stromal scarring
• Dense central opacity in advanced cases

Prominent Corneal Nerves

Corneal nerves may appear unusually visible on slit-lamp examination.

Acute Corneal Hydrops

Acute hydrops occurs when Descemet membrane ruptures.

Aqueous rapidly enters the corneal stroma and causes:

• Sudden severe corneal edema
• Marked reduction in vision
• Pain or photophobia
• Epithelial bullae

Hydrops usually resolves gradually over weeks to months but may leave significant scarring.

Diagnostic Tests and Interpretation

Corneal Topography

Corneal topography is one of the most important diagnostic tests.

Typical findings include:

• Inferior or inferotemporal steepening
• High keratometric values
• Asymmetric bow-tie pattern
• Skewed radial axes
• Irregular astigmatism

Topography can detect disease before obvious slit-lamp findings appear.

Corneal Tomography

Modern tomography evaluates both the anterior and posterior corneal surfaces.

Scheimpflug-based systems such as Pentacam can demonstrate:

• Anterior elevation
• Posterior elevation
• Abnormal corneal thickness distribution
• Decentered thinnest point
• Progressive ectatic change

Posterior corneal elevation may become abnormal relatively early in the disease.

Pachymetry

Corneal thickness mapping shows:

• Localized thinning
• An abnormally displaced thinnest point
• Abnormal progression of thickness from center to periphery

Serial pachymetry is useful in monitoring progression.

Anterior-Segment OCT

Anterior-segment OCT can provide detailed maps of:

• Corneal thickness
• Epithelial thickness
• Stromal abnormalities

It can also help distinguish keratoconus from other forms of corneal irregularity.

Wavefront Aberrometry

Keratoconus produces increased higher-order aberrations, particularly vertical coma.

This helps explain why patients may have poor visual quality even when standard refractive error appears reasonably corrected.

Pathological Findings

Microscopic changes may involve all corneal layers.

Possible findings include:

• Epithelial thinning
• Degeneration of basal epithelial cells
• Iron deposition
• Breaks in Bowman layer
• Altered stromal collagen arrangement
• Stromal thinning
• Endothelial pleomorphism and polymegathism

The exact pathologic appearance varies with disease severity.

Differential Diagnosis

Important differential diagnoses include:

• Physiologic astigmatism
• Pellucid marginal degeneration
• Keratoglobus
• Post-refractive surgery ectasia
• Contact lens-induced corneal warpage
• Traumatic corneal scarring

Treatment

Management depends on:

• Severity
• Evidence of progression
• Age
• Visual needs
• Presence of scarring
• Contact lens tolerance

The goals are to improve vision and, when possible, stop progression.

Spectacles

Glasses may provide satisfactory vision in early disease when astigmatism remains relatively regular.

As irregularity increases, spectacles become less effective.

Contact Lenses

Soft Contact Lenses

Soft toric lenses may work in mild disease with relatively regular astigmatism.

Rigid Gas-Permeable Lenses

RGP lenses are commonly used because the rigid front surface provides a more regular refractive interface over the irregular cornea.

They can significantly improve vision.

Piggyback Systems

A soft lens may be worn underneath an RGP lens to improve comfort.

Hybrid Lenses

Hybrid lenses combine a rigid center with a soft peripheral skirt.

Scleral Lenses

Scleral lenses vault over the cornea and rest on the sclera.

They are particularly useful for:

• Advanced irregularity
• Contact lens intolerance
• Corneal scarring
• Severe visual distortion

Corneal Cross-Linking

Corneal collagen cross-linking is now a major treatment for progressive keratoconus.

It uses riboflavin and ultraviolet-A light to strengthen corneal collagen and increase biomechanical stability.

The primary goal is to halt or slow progression, not necessarily to restore normal corneal shape.

Cross-linking is particularly important in:

• Young patients
• Documented progression
• Increasing steepness
• Increasing refractive error
• Progressive thinning

Early treatment can reduce the likelihood of later transplantation.

Intrastromal Corneal Ring Segments

Intrastromal ring segments may be considered in selected patients.

They can:

• Flatten the cone
• Reduce irregularity
• Improve spectacle or contact lens tolerance

They do not reliably stop progression, so cross-linking may still be necessary when the disease is progressing.

Treatment of Acute Hydrops

Management is mainly supportive.

Options may include:

• Cycloplegic drops
• Hypertonic sodium chloride drops or ointment
• Lubrication
• Bandage contact lens in selected cases
• Pain control

More advanced procedures may be considered by a corneal specialist in severe hydrops.

Patients require close follow-up until the edema resolves.

Corneal Transplantation

Corneal transplantation may be necessary when there is:

• Severe corneal scarring
• Contact lens intolerance
• Advanced ectasia
• Poor functional vision despite other measures

Deep Anterior Lamellar Keratoplasty

DALK replaces the diseased corneal stroma while preserving the patient’s own endothelium.

It is often preferred when technically feasible because it avoids endothelial rejection.

Penetrating Keratoplasty

Full-thickness transplantation may be required in selected advanced cases.

Keratoconus generally has a good graft prognosis compared with many other indications for corneal transplantation.

Referral

Referral to an experienced contact lens specialist is appropriate when conventional correction is inadequate.

Referral to a corneal specialist is indicated for:

• Documented progression
• Consideration of cross-linking
• Acute hydrops
• Significant scarring
• Contact lens intolerance
• Consideration of ring segments or transplantation

Follow-Up

Stable patients should generally have periodic examinations, often at least annually.

Younger patients and those with documented progression require more frequent monitoring.

Follow-up may include:

• Refraction
• Visual acuity
• Corneal topography
• Tomography
• Pachymetry

Patients with acute hydrops may need review every few weeks until resolution.

Patient Education

Patients should be strongly advised:

• Do not rub the eyes
• Treat ocular allergy appropriately
• Attend regular corneal imaging appointments
• Report sudden visual deterioration promptly
• Understand that progression can occur even when vision seems relatively stable

Family members may also benefit from screening when there is a strong family history.

Prognosis

The clinical course is highly variable.

Some patients remain mild and stable for years, while others progress rapidly.

Progression is generally more likely in:

• Younger patients
• Eyes with steeper corneas
• Patients with significant eye rubbing
• Patients with documented serial changes

Modern cross-linking has substantially improved the ability to stabilize progressive disease.

Complications

Potential complications include:

• Progressive irregular astigmatism
• Severe visual distortion
• Contact lens intolerance
• Corneal scarring
• Acute hydrops
• Rare corneal perforation
• Need for corneal transplantation

The key clinical pearl is: keratoconus should be suspected in a young patient with progressive asymmetric myopia and astigmatism, reduced spectacle-corrected vision, and corneal topography showing inferior or inferotemporal steepening.

Ophthalmology – Kawasaki Disease

Basics

Description

Kawasaki disease (KD) is an acute, systemic medium-vessel vasculitis occurring predominantly in infants and young children.

Its greatest clinical importance is the risk of coronary artery abnormalities, particularly coronary artery aneurysms.

Classic Kawasaki disease is characterized by fever plus characteristic mucocutaneous findings:

• Bilateral nonexudative conjunctival injection
• Oral and lip changes
• Cervical lymphadenopathy
• Changes of the hands and feet
• Polymorphous rash

From an ophthalmic perspective, bilateral conjunctival injection is one of the principal diagnostic features, while mild anterior uveitis is also relatively common.

Epidemiology

Kawasaki disease occurs worldwide but has its highest incidence among children of East Asian ancestry, particularly in Japan.

Most affected children are younger than 5 years.

Other epidemiologic features include:

• Male predominance
• Peak occurrence during infancy and early childhood
• Seasonal variation in many regions

The disease is uncommon in very young neonates and older children, although it can occur at any pediatric age.

Risk Factors

Important factors include:

• Genetic susceptibility
• Young age
• Male sex
• Asian ancestry
• Family history of Kawasaki disease

A delay in diagnosis and treatment increases the risk of coronary artery complications.

Prolonged or persistent fever is also associated with greater cardiovascular risk.

Genetics

Kawasaki disease has a genetic component, but inheritance is complex.

Several susceptibility loci have been identified, including polymorphisms involving ITPKC.

Genetic susceptibility probably interacts with environmental or infectious triggers to produce the inflammatory response.

Etiology

The exact cause remains unknown.

The leading concept is that an unidentified environmental or infectious trigger produces an abnormal immune response in a genetically susceptible child.

Kawasaki disease itself is not considered a conventional contagious infection.

Pathophysiology

Kawasaki disease produces systemic vasculitis, with particularly important involvement of medium-sized muscular arteries.

The inflammatory process progresses through several stages.

Initially, there is:

• Neutrophilic infiltration
• Vascular edema
• Endothelial injury

This is followed by infiltration with:

• T lymphocytes
• Plasma cells
• Monocytes
• Macrophages

Inflammatory enzymes, including matrix metalloproteinases, can damage the arterial media and internal elastic lamina.

This weakening of the arterial wall can result in coronary artery dilation and aneurysm formation.

Later, healing may produce fibrosis, vascular remodeling, stenosis, or thrombosis.

Clinical Diagnosis

Kawasaki disease is primarily a clinical diagnosis.

The classic presentation consists of prolonged fever accompanied by the characteristic clinical features.

Fever

Fever is typically:

• High
• Persistent
• Often ≥39°C
• Poorly responsive to routine antipyretics

Untreated fever may persist for one to several weeks.

Major Clinical Features

1. Bilateral Conjunctival Injection

This is the major ophthalmic feature.

Typical findings are:

• Bilateral
• Bulbar
• Nonpurulent
• Nonexudative
• Usually painless

The conjunctival redness generally occurs without the thick discharge typical of bacterial conjunctivitis.

2. Oral and Oropharyngeal Changes

Typical findings include:

• Bright red lips
• Dry or cracked lips
• Diffuse oral mucosal erythema
• Strawberry tongue

Oral ulceration and exudative tonsillitis are not typical and should suggest alternative diagnoses.

3. Cervical Lymphadenopathy

Usually:

• Nonpurulent
• Cervical
• Often unilateral

At least one lymph node may be markedly enlarged.

This is generally the least frequently encountered of the classic diagnostic features.

4. Extremity Changes

During the acute phase:

• Erythema of palms and soles
• Edema of hands and feet

During the subacute phase:

• Periungual desquamation of fingers and toes

Peeling typically begins approximately 1–3 weeks after disease onset.

5. Polymorphous Rash

A generalized rash commonly involves the trunk and extremities.

It may have several appearances but is generally nonvesicular.

Perineal erythema and subsequent desquamation may also occur.

Ocular Manifestations

Conjunctival Injection

Bilateral nonexudative conjunctival injection is one of the defining clinical manifestations of Kawasaki disease.

It usually resolves as the systemic inflammatory process improves.

Anterior Uveitis

Kawasaki disease can produce a mild bilateral anterior uveitis.

Slit-lamp examination may demonstrate:

• Anterior chamber cells
• Mild flare

The uveitis is generally:

• Mild
• Transient
• Bilateral
• Self-limited

It usually improves as the systemic disease is treated.

Topical corticosteroids are usually unnecessary, although ophthalmic treatment may be required when inflammation is more significant.

Other Ocular Manifestations

Less common manifestations include:

• Superficial punctate keratitis
• Choroiditis
• Optic disc swelling
• Other posterior segment inflammatory abnormalities

Severe ocular disease is unusual.

Associated Systemic Findings

Kawasaki disease may also produce:

• Marked irritability
• Arthritis or arthralgia
• Myocarditis
• Pericarditis
• Gastrointestinal symptoms
• Abdominal pain
• Vomiting
• Diarrhea
• Hepatitis
• Gallbladder hydrops
• Sterile pyuria
• Aseptic meningitis
• Otitis media

The major concern remains cardiovascular involvement.

Coronary Artery Disease

The most important complication is coronary artery involvement.

Possible abnormalities include:

• Coronary dilation
• Coronary aneurysm
• Giant coronary aneurysm
• Coronary thrombosis
• Coronary stenosis
• Myocardial ischemia
• Myocardial infarction

Untreated Kawasaki disease has a substantial risk of coronary artery abnormalities.

Prompt treatment with IVIG dramatically reduces this risk.

Diagnostic Testing

There is no single laboratory test that confirms Kawasaki disease.

Laboratory investigations support the diagnosis and help assess disease severity.

Common abnormalities include:

• Elevated CRP
• Elevated ESR
• Leukocytosis with neutrophilia
• Normocytic anemia
• Elevated hepatic transaminases
• Hypoalbuminemia
• Sterile pyuria

Platelet counts may initially be normal.

During the subacute phase, thrombocytosis commonly develops.

Cardiac Evaluation

Echocardiography

Echocardiography is essential for evaluating:

• Coronary artery dimensions
• Coronary aneurysms
• Ventricular function
• Pericardial effusion
• Other cardiac abnormalities

Importantly, a normal early echocardiogram does not exclude Kawasaki disease.

Serial cardiac imaging is determined by the patient’s coronary findings and clinical course.

Ophthalmic Examination

Routine ophthalmologic consultation is not necessary for every uncomplicated case.

An ophthalmic examination is particularly appropriate when there is:

• Suspected anterior uveitis
• Significant photophobia
• Reduced vision
• Persistent ocular inflammation
• Atypical ocular manifestations

Slit-lamp examination can detect mild anterior chamber inflammation that is not obvious externally.

Differential Diagnosis

Important differential diagnoses include:

• Adenovirus infection
• Scarlet fever
• Toxic shock syndrome
• Measles
• Drug hypersensitivity reactions
• Stevens–Johnson syndrome
• Systemic juvenile idiopathic arthritis
• Other systemic vasculitides
• Bacterial cervical lymphadenitis

Adenovirus can be particularly confusing because both conditions can produce fever and conjunctival injection.

However, exudative conjunctivitis and pharyngitis favor adenovirus rather than classic Kawasaki disease.

Incomplete Kawasaki Disease

Some children do not meet all of the classic clinical criteria but still have Kawasaki disease.

This is known as incomplete Kawasaki disease.

It is especially important to consider in:

• Young infants
• Children with prolonged unexplained fever
• Patients with compatible laboratory abnormalities
• Patients with coronary artery abnormalities

Incomplete disease can still cause serious coronary complications and should not be considered a mild form of Kawasaki disease.

Treatment

Intravenous Immunoglobulin

IVIG is the cornerstone of treatment.

Standard initial therapy is:

IVIG 2 g/kg as a single infusion.

Treatment should be administered promptly once the diagnosis is established.

Early IVIG substantially reduces the risk of coronary artery aneurysm formation.

Aspirin

Aspirin is traditionally given during the acute inflammatory phase, followed by low-dose antiplatelet aspirin.

Low-dose aspirin is generally continued until follow-up confirms the absence of clinically important coronary abnormalities.

Patients with persistent coronary artery abnormalities may require longer antiplatelet therapy.

Exact aspirin dosing and duration should follow current pediatric cardiology/Kawasaki disease protocols.

IVIG-Resistant Disease

Some children have persistent or recurrent fever after initial IVIG.

Depending on the clinical situation, additional treatment may include:

• Repeat IVIG
• Systemic corticosteroids
• Infliximab
• Other immunomodulatory therapy

High-risk children may receive corticosteroids as part of initial therapy rather than waiting for IVIG resistance.

Antithrombotic Therapy

Children with significant coronary aneurysms may require more intensive thrombosis prevention.

Depending on aneurysm size and other risk factors, treatment may include:

• Aspirin
• Additional antiplatelet agents
• Anticoagulation

Management should be directed by pediatric cardiology.

Treatment of Ocular Disease

The conjunctival injection generally requires no specific ocular treatment.

Mild anterior uveitis typically resolves with systemic treatment.

More significant anterior uveitis may occasionally require:

• Topical corticosteroids
• Cycloplegic agents

These should be managed by an ophthalmologist.

Hospital Management

Children with suspected acute Kawasaki disease generally require hospital evaluation and treatment.

Management includes:

• IVIG
• Anti-inflammatory/antiplatelet therapy
• Cardiac assessment
• Laboratory monitoring
• Echocardiography

Fluid management may be necessary in children with significant gastrointestinal symptoms or dehydration.

Follow-Up

Long-term follow-up depends predominantly on coronary artery involvement.

Children without coronary abnormalities generally require substantially less intensive long-term cardiac surveillance than children with persistent aneurysms.

Patients with coronary aneurysms may require:

• Serial echocardiography
• ECG
• Additional coronary imaging
• Stress testing
• Long-term antithrombotic therapy

Large or giant aneurysms require particularly close lifelong cardiology surveillance.

Ophthalmology Follow-Up

Ophthalmic follow-up is primarily indicated when:

• Anterior uveitis is present
• Ocular inflammation persists
• Vision is reduced
• Atypical ocular manifestations develop

Most conjunctival and mild inflammatory ocular manifestations resolve without permanent visual consequences.

Prognosis

With prompt diagnosis and appropriate treatment, the prognosis is generally excellent.

IVIG dramatically decreases the frequency of coronary artery aneurysms.

Long-term prognosis is primarily determined by the presence, size, and persistence of coronary artery abnormalities.

Complications

The major complications are cardiovascular:

• Coronary artery aneurysm
• Coronary thrombosis
• Coronary stenosis
• Myocardial ischemia
• Myocardial infarction
• Arrhythmia
• Rare sudden cardiac death

The key ophthalmology pearl is: bilateral, nonpurulent conjunctival injection in a persistently febrile young child—particularly when accompanied by strawberry tongue, rash, extremity changes, or cervical lymphadenopathy—should immediately raise suspicion for Kawasaki disease.

Ophthalmology – Juvenile Xanthogranuloma (Nevoxanthoendothelioma)

Basics

Description

Juvenile xanthogranuloma (JXG) is a benign non-Langerhans cell histiocytic disorder that occurs mainly in infants and young children.

It is usually a self-limited skin disease, producing yellow-tan papules or nodules on the head, neck, trunk, or extremities.

Extracutaneous involvement occurs in a small percentage of patients and may involve:

• Eye
• Lung
• Gastrointestinal tract
• Bone
• Muscle

Ocular involvement can affect:

• Iris
• Eyelid
• Cornea
• Conjunctiva
• Ciliary body
• Choroid
• Episclera
• Orbit
• Posterior segment

The iris is the most important ocular site, because involvement can cause spontaneous hyphema and secondary glaucoma.

Epidemiology

The true incidence of JXG is uncertain because many cutaneous lesions regress spontaneously and may never be diagnosed.

Most cases occur in early childhood.

Approximately:

• 10% are present at birth
• Most develop during the first year of life
• Solitary skin lesions are more common than multiple lesions

Ocular disease occurs predominantly in very young children and is usually unilateral.

Only about half of children with ocular JXG have obvious skin lesions, so absence of a cutaneous lesion does not exclude ocular disease.

Pathophysiology

JXG is believed to result from a reactive proliferation of histiocytes rather than a true neoplasm.

The trigger is uncertain but may involve a nonspecific inflammatory response to physical or infectious stimuli.

Affected tissues accumulate:

• Histiocytes
• Lipid-laden foam cells
• Multinucleated giant cells

The characteristic histologic cell is the Touton giant cell.

Commonly Associated Conditions

Important associations include:

Neurofibromatosis Type 1

JXG may occur in children with NF1.

Children with the combination of:

• NF1
• JXG

have historically been recognized as having an increased association with juvenile myelomonocytic leukemia, although the magnitude of this association varies among studies.

Juvenile Myelomonocytic Leukemia

JMML is a rare myeloproliferative disorder of early childhood.

Because iris infiltration from leukemia can mimic ocular JXG, atypical cases require careful systemic evaluation.

Niemann–Pick Disease

Rarely associated with xanthomatous lesions and systemic storage disease.

Urticaria Pigmentosa

A form of cutaneous mastocytosis that may coexist with other pediatric dermatologic lesions.

Diagnosis

History

Many children are asymptomatic.

Parents may notice:

• Yellow-orange skin nodules
• Change in iris color
• Red eye
• Visible blood in the eye
• Enlarged pupil
• Reduced vision
• Eye pain
• Photophobia

Pain and photophobia may occur when secondary glaucoma develops.

Because children may not report visual symptoms reliably, careful examination is essential.

Cutaneous Findings

Typical skin lesions are:

• Firm
• Tan, yellow, orange, or reddish
• Papular or nodular
• Usually located on the head, neck, trunk, or extremities

They may be solitary or multiple.

Most lesions gradually regress spontaneously.

Ocular Findings

Ocular JXG may produce:

• Spontaneous hyphema
• Vascular yellow-brown iris mass
• Heterochromia
• Unilateral anterior uveitis
• Secondary glaucoma
• Corneal blood staining
• Cataract
• Conjunctival mass
• Proptosis
• Retinal vascular occlusion
• Retinal detachment
• Amblyopia

A young child with unilateral spontaneous hyphema and glaucoma should prompt consideration of JXG.

Iris Involvement

The iris may appear:

• Thickened
• Diffusely infiltrated
• Nodular
• Yellow-brown
• Highly vascular

Fragile abnormal vessels can bleed spontaneously, causing hyphema.

Iris infiltration may also obstruct the anterior chamber angle and elevate IOP.

Secondary Glaucoma

Glaucoma may result from:

• Obstruction of the trabecular meshwork by inflammatory or histiocytic material
• Peripheral anterior synechiae
• Blood in the anterior chamber
• Steroid response
• Structural angle damage

This is one of the most important causes of visual loss in ocular JXG.

Physical Examination

A complete examination should include:

• Skin examination of head, neck, trunk, and extremities
• Visual acuity assessment
• Pupillary examination
• Intraocular pressure
• Slit-lamp examination
• Gonioscopy when feasible
• Dilated fundus examination

In young children, examination under anesthesia may occasionally be required.

Diagnostic Tests

Biopsy

Diagnosis can be confirmed by biopsy of:

• Skin lesion
• Iris lesion
• Other involved tissue

For iris disease, biopsy options may include:

• Fine-needle aspiration
• Iridectomy
• Iridocyclectomy

Biopsy is generally reserved for cases in which the clinical diagnosis is uncertain or malignancy cannot be excluded.

Pathological Findings

Classic histology demonstrates:

• Histiocytes
• Foam cells
• Lymphocytes
• Plasma cells
• Multinucleated giant cells

The characteristic finding is the Touton giant cell.

Touton giant cells contain a ring of nuclei surrounded by foamy, lipid-containing cytoplasm.

Immunohistochemistry typically shows positivity for histiocytic markers such as:

• CD68
• CD163
• Factor XIIIa

Cells are generally negative for:

• CD1a
• S-100

This helps distinguish JXG from Langerhans cell histiocytosis.

Differential Diagnosis

Important differential diagnoses include:

• Leukemic iris infiltration
• Iris nevus
• Iris melanoma
• Langerhans cell histiocytosis
• Rhabdomyosarcoma
• Dermoid
• Xanthoma
• Hemangioma
• Neurofibroma
• Molluscum contagiosum
• Juvenile idiopathic arthritis-associated uveitis

The combination of a vascular iris lesion, spontaneous hyphema, and secondary glaucoma in a young child is especially suggestive of JXG.

Treatment

Treatment depends on the site and severity of disease.

Many cutaneous lesions require no treatment because they regress spontaneously.

Ocular disease requires more aggressive management because of the risk of permanent visual loss.

Corticosteroids

Systemic corticosteroids may be used for significant ocular or extracutaneous disease.

Topical corticosteroids may be used for associated anterior segment inflammation.

In selected refractory cases, additional immunomodulatory therapy may be considered.

Management of Hyphema

Spontaneous hyphema should be treated with standard precautions.

Management may include:

• Cycloplegic drops
• Topical corticosteroids
• Eye shield
• Head elevation
• Avoidance of strenuous activity
• Avoidance of unnecessary anticoagulant or antiplatelet exposure

IOP should be monitored closely.

Management of Glaucoma

Elevated IOP should be treated promptly.

Initial treatment may include topical pressure-lowering medications.

If glaucoma is severe or uncontrolled, surgical management may be necessary.

Because these are young children, prolonged elevation of IOP can cause rapid and permanent optic nerve damage.

Amblyopia Treatment

Amblyopia is an important secondary complication.

It can result from:

• Cataract
• Corneal blood staining
• Strabismus
• Anisometropia
• Glaucoma
• Prolonged visual deprivation

Treatment may include:

• Refractive correction
• Patching
• Atropine penalization
• Treatment of the underlying ocular lesion

Early treatment is essential.

Surgery

Surgical procedures may be required for:

• Local resection of persistent lesions
• Cataract extraction
• Glaucoma surgery
• Removal of visually significant iris or conjunctival masses

Surgery is individualized according to the affected structure and visual threat.

Follow-Up

Children with ocular JXG should be followed by an ophthalmologist, often with pediatric ophthalmology involvement.

Monitoring should include:

• Visual acuity
• IOP
• Anterior chamber inflammation
• Hyphema recurrence
• Cataract
• Corneal blood staining
• Optic nerve appearance
• Amblyopia

A primary care physician or dermatologist should follow associated skin lesions.

Patient Education

Parents should understand that most skin lesions are benign and self-limited.

However, ocular involvement can be serious.

They should seek prompt ophthalmic evaluation for:

• Red eye
• Eye pain
• Photophobia
• Visible blood in the eye
• Change in iris color
• New squint
• Reduced visual behavior

Prognosis

The systemic prognosis is generally excellent.

Most children have:

• Normal development
• Normal intelligence
• Normal lifespan
• Spontaneous regression of cutaneous lesions

The ocular prognosis depends on early recognition and control of complications.

Vision can be permanently reduced if secondary glaucoma, cataract, corneal blood staining, or amblyopia develops.

Complications

Important complications include:

• Secondary glaucoma
• Recurrent hyphema
• Corneal blood staining
• Cataract
• Amblyopia
• Retinal detachment
• Severe permanent visual loss

The key clinical pearl is: a young child with unilateral spontaneous hyphema, a vascular yellow-brown iris lesion, and secondary glaucoma should raise strong suspicion for juvenile xanthogranuloma.

Ophthalmology – Juvenile Idiopathic Arthritis-Related Uveitis

Basics

Description

Juvenile idiopathic arthritis (JIA)-related uveitis is an important cause of chronic anterior uveitis in children with juvenile idiopathic arthritis.

JIA is defined as arthritis beginning before 16 years of age, persisting for more than 6 weeks, and occurring without another identifiable cause.

The major JIA categories include:

• Systemic arthritis
• Oligoarthritis
• Rheumatoid factor-negative polyarthritis
• Rheumatoid factor-positive polyarthritis
• Psoriatic arthritis
• Enthesitis-related arthritis
• Undifferentiated arthritis

Among these, oligoarticular JIA carries the greatest classic risk of chronic asymptomatic anterior uveitis.

A major clinical problem is that the eye may remain white and painless despite significant intraocular inflammation.

Epidemiology

The exact incidence and prevalence of JIA vary widely among populations.

Reported incidence ranges from approximately 0.008 to 0.226 per 1,000 children per year.

Reported prevalence ranges from approximately 0.07 to 4 per 1,000 children.

Uveitis develops in a minority of children with JIA, but the proportion varies substantially by population and JIA subtype.

Overall, approximately 8–10% of children with JIA develop uveitis, although individual studies have reported much wider ranges.

Risk Factors

Important risk factors for JIA-associated uveitis include:

• Positive ANA
• Young age at onset of arthritis
• Female sex
• Oligoarticular disease
• Early duration after JIA diagnosis

Children who develop arthritis at a younger age generally carry a greater risk than those with later-onset disease.

Genetics

JIA is genetically complex.

Certain HLA associations have been reported.

HLA-DRB1 alleles have been linked with susceptibility to JIA, and some studies have associated HLA-DRB1*13 with increased risk of uveitis.

No single genetic abnormality explains JIA-related uveitis.

Pathophysiology

The exact mechanism is not fully understood.

JIA is considered an immune-mediated inflammatory disease involving abnormal regulation of both innate and adaptive immunity.

Autoantibodies such as:

• ANA
• Rheumatoid factor
• Anti-cyclic citrullinated peptide antibodies

may be present in some patients, but the exact ocular antigen responsible for uveitis remains unknown.

Persistent inflammation within the anterior chamber can damage multiple ocular structures over time.

Etiology

The precise cause is unknown.

JIA-related uveitis is believed to result from a combination of:

• Genetic susceptibility
• Immune dysregulation
• Environmental triggers

JIA Subtypes

Systemic JIA

Systemic arthritis involves one or more joints with fever and may be associated with:

• Evanescent rash
• Generalized lymphadenopathy
• Hepatomegaly
• Splenomegaly
• Serositis

This subtype has a relatively low risk of chronic uveitis.

Oligoarthritis

Oligoarthritis affects 1–4 joints during the first 6 months.

It is divided into:

• Persistent oligoarthritis
• Extended oligoarthritis

This subtype is particularly important because it carries one of the highest risks of chronic asymptomatic uveitis.

Polyarthritis

Polyarthritis affects 5 or more joints during the first 6 months.

It is divided into:

• RF-negative polyarthritis
• RF-positive polyarthritis

Uveitis risk is generally lower than in oligoarticular JIA.

Psoriatic Arthritis

This category includes arthritis with psoriasis or arthritis associated with features such as:

• Dactylitis
• Nail pitting
• Onycholysis
• First-degree relative with psoriasis

Uveitis can occur.

Enthesitis-Related Arthritis

ERA is associated with inflammation at tendon or ligament insertions.

Features may include:

• Sacroiliac tenderness
• HLA-B27 positivity
• Male sex with onset after age 6
• Acute symptomatic anterior uveitis
• Family history of ankylosing spondylitis or related disorders

Unlike classic JIA-associated chronic uveitis, ERA-associated uveitis is often acute, painful, red, and photophobic.

Undifferentiated Arthritis

This includes children who do not clearly meet criteria for a single category or fulfill criteria for multiple categories.

Diagnosis

History

Many children with JIA-related uveitis have no ocular symptoms at all.

This is the reason regular ophthalmic screening is mandatory.

When symptoms are present, ask about:

• Decreased vision
• Photophobia
• Redness
• Eye pain
• Previous episodes labeled as “pink eye”
• Floaters

The absence of symptoms does not rule out active disease.

Clinical Classification

Using standard uveitis terminology, anterior inflammation may be described as:

Acute Anterior Uveitis

Sudden-onset anterior uveitis of limited duration.

Recurrent Anterior Uveitis

Repeated episodes separated by periods of inactivity without treatment.

Chronic Anterior Uveitis

Inflammation persisting for more than approximately 3 months or recurring quickly when treatment is stopped.

This is the classic form seen with JIA.

Anterior Uveitis With Vitreous Involvement

Anterior inflammation may occasionally be associated with true vitreous inflammatory cells.

Physical Examination

JIA-related uveitis is usually:

• Anterior
• Chronic
• Nongranulomatous
• Bilateral or eventually bilateral

Both eyes may become involved within months of one another.

Although traditionally considered nongranulomatous, some children can show granulomatous features.

Anterior Chamber Findings

Slit-lamp examination may demonstrate:

• Inflammatory cells
• Flare
• Posterior synechiae

Treatment decisions should be guided primarily by the cellular inflammatory activity, not by flare alone.

Persistent flare may reflect chronic breakdown of the blood-aqueous barrier even after active cellular inflammation has improved.

Posterior Synechiae

Posterior synechiae occur when the posterior iris adheres to the anterior lens capsule.

They can lead to:

• Irregular pupil
• Poor dilation
• Pupillary block
• Secondary angle closure

Preventing synechiae is an important treatment goal.

Band Keratopathy

Band keratopathy is a classic complication of chronic pediatric uveitis.

Calcium deposits accumulate within the superficial cornea, typically across the interpalpebral zone.

Severe band keratopathy may reduce vision and cause discomfort.

Cataract

Cataract is one of the most important vision-threatening complications.

It can result from:

• Chronic inflammation
• Corticosteroid treatment
• Posterior synechiae

Posterior subcapsular cataract is particularly common.

Glaucoma

Secondary glaucoma may develop from:

• Chronic inflammation
• Peripheral anterior synechiae
• Steroid response
• Trabecular damage
• Angle closure

Glaucoma can be difficult to detect in children and may progress silently.

Hypotony

Severe chronic inflammation can impair ciliary body function and lead to ocular hypotony.

Longstanding hypotony can produce:

• Maculopathy
• Structural ocular damage
• Phthisis bulbi in severe cases

Cystoid Macular Edema

CME is an important cause of decreased vision.

OCT should be obtained when central visual acuity is reduced or macular involvement is suspected.

Diagnostic Tests

Laboratory Testing

There is no laboratory test that confirms JIA-related uveitis.

JIA remains a clinical diagnosis of exclusion.

When the systemic diagnosis has not already been established, investigations may include:

• ESR
• CRP
• Platelet count
• ANA
• RF
• Anti-CCP

Testing for alternative causes may be considered when the presentation is atypical, including:

• Lyme disease
• Sarcoidosis
• Tuberculosis
• Other infectious or inflammatory disorders

Optical Coherence Tomography

OCT is particularly useful when:

• Visual acuity is reduced
• CME is suspected
• Macular structural damage needs monitoring

It provides an objective method of monitoring macular response to treatment.

Differential Diagnosis

The most important differential diagnoses include:

• Sarcoidosis
• Lyme disease
• Herpetic keratouveitis
• Trauma
• Kawasaki disease
• Other pediatric inflammatory conditions

Sarcoidosis can closely resemble JIA-associated uveitis and should be considered in atypical or granulomatous cases.

Treatment Goals

The goals are to:

• Eliminate active inflammation
• Prevent synechiae
• Preserve vision
• Minimize corticosteroid toxicity
• Prevent cataract and glaucoma
• Maintain long-term quiescence

Because children may need years of treatment, long-term safety is especially important.

First-Line Treatment

Topical Corticosteroids

Topical corticosteroids are first-line treatment for active anterior uveitis.

The dose is adjusted according to:

• Anterior chamber cell count
• Severity of inflammation
• Presence of synechiae
• Response to treatment

The goal is to achieve complete control while using the lowest effective steroid exposure.

Persistent need for frequent topical corticosteroid dosing suggests the need for steroid-sparing systemic therapy.

Cycloplegics and Mydriatics

Short-acting cycloplegics are used to:

• Prevent posterior synechiae
• Relieve ciliary spasm
• Reduce pain
• Maintain pupillary mobility

Long-term continuous cycloplegia should be used thoughtfully because blur and amblyopia can be important issues in young children.

Periocular Corticosteroids

Periocular steroid injections may occasionally be used for severe or refractory inflammation.

However, they carry significant risks, particularly:

• Cataract
• Ocular hypertension
• Glaucoma

They are therefore used selectively.

Systemic Corticosteroids

Oral or intravenous corticosteroids may be used for severe disease, but prolonged systemic steroid therapy should generally be avoided in children because of:

• Growth suppression
• Bone effects
• Metabolic complications
• Immune suppression

They are often used as temporary bridging therapy rather than as the primary long-term strategy.

Methotrexate

Methotrexate is a major first-line steroid-sparing systemic treatment for JIA-associated uveitis.

It is especially useful when:

• Topical corticosteroids cannot be reduced adequately
• Inflammation remains active
• Bilateral chronic disease is present
• Steroid toxicity is developing

Clinical response may take several weeks.

Monitoring generally includes:

• CBC
• Liver function tests

The exact monitoring schedule is coordinated with pediatric rheumatology.

Biologic Therapy

Biologic agents are important for disease that is inadequately controlled with conventional therapy.

Adalimumab

Adalimumab is strongly established as an effective therapy for JIA-associated uveitis, particularly when methotrexate alone is insufficient.

Infliximab

Infliximab can also be effective in selected refractory cases.

Etanercept

Although effective for joint disease, etanercept is not considered an effective treatment for JIA-associated uveitis and is generally not preferred when ocular inflammation is a major concern.

Other Immunomodulatory Agents

Additional steroid-sparing treatments may include:

• Mycophenolate mofetil
• Azathioprine
• Cyclosporine
• Tacrolimus

Choice depends on disease severity, response, systemic manifestations, and specialist experience.

Surgical Treatment

Cataract Surgery

Cataract is a frequent complication.

Modern management may include:

• Phacoemulsification
• Posterior capsulotomy or capsulorrhexis
• Anterior vitrectomy when appropriate
• Intraocular lens implantation in selected well-controlled cases

The most important principle is that uveitis should be well controlled before cataract surgery whenever possible.

Poorly controlled inflammation increases the risk of severe postoperative complications.

Glaucoma Surgery

When topical medications fail, surgical options may include:

• Trabeculectomy with antimetabolite
• Glaucoma drainage device

Glaucoma surgery in uveitic children can be challenging and often requires specialist management.

Band Keratopathy Treatment

Visually significant or symptomatic band keratopathy may be treated with EDTA chelation.

Recurrence can occur, particularly if inflammation remains active.

Ongoing Care

Follow-Up Recommendations

Children with JIA should undergo scheduled ophthalmic screening according to:

• Age at arthritis onset
• JIA subtype
• ANA status
• Duration of disease
• Previous history of uveitis

Screening is essential even when the child has no eye symptoms.

Patient Monitoring

Monitoring should include:

• Visual acuity
• Amblyopia assessment
• Slit-lamp examination
• Anterior chamber cell grading
• IOP measurement
• Lens evaluation
• Corneal evaluation
• Posterior segment examination
• OCT when indicated

Systemic medication toxicity must also be monitored.

Multidisciplinary Care

Management ideally involves:

• Pediatric ophthalmologist
• Pediatric rheumatologist
• Uveitis specialist when necessary

Close communication between specialists is important because arthritis activity and ocular inflammation can behave independently.

Patient and Parent Education

Parents should understand that JIA-associated uveitis is often completely asymptomatic.

A child can have serious intraocular inflammation despite:

• No pain
• No redness
• No photophobia
• No obvious visual complaint

Therefore, scheduled screening visits should not be skipped simply because the eyes appear normal.

Any episode of persistent red eye in a child with JIA should be evaluated rather than automatically assumed to be viral conjunctivitis.

Prognosis

Modern outcomes have improved significantly with:

• Earlier screening
• Aggressive control of inflammation
• Steroid-sparing immunomodulatory therapy
• Biologic treatment

Many children can retain excellent functional vision when disease is identified early and controlled adequately.

Delayed diagnosis and longstanding inflammation increase the risk of irreversible visual loss.

Complications

Important complications include:

• Cataract
• Band keratopathy
• Posterior synechiae
• Secondary glaucoma
• Cystoid macular edema
• Hypotony
• Amblyopia
• Permanent visual loss
• Phthisis bulbi in severe end-stage disease

The key clinical pearl is: JIA-related uveitis can be severe in a completely white, quiet, asymptomatic eye, so routine slit-lamp screening is essential for children at risk.

Ophthalmology – Isolated Trochlear Nerve (Cranial Nerve IV) Palsy

Basics

Description

A trochlear nerve, or cranial nerve IV, palsy causes weakness or paralysis of the superior oblique muscle.

The superior oblique primarily contributes to:

• Depression of the eye in adduction
• Intorsion
• Abduction to a lesser degree

When the trochlear nerve is weak, patients typically develop vertical or oblique binocular diplopia, often worse when looking downward.

Epidemiology

Trochlear nerve palsy is relatively common after closed head trauma.

The trochlear nerve is particularly vulnerable because it:

• Has a long intracranial course
• Exits dorsally from the brainstem
• Decussates before reaching the orbit

These anatomic features make it susceptible to traumatic injury.

Etiology

Common causes include:

• Congenital trochlear nerve palsy
• Head trauma
• Microvascular ischemia

Less common causes include:

• Tumors
• Pineal region lesions
• Tentorial meningioma
• Aneurysm
• Meningitis
• Giant cell arteritis

In adults, vascular risk factors such as diabetes and hypertension may contribute to microvascular trochlear nerve palsy.

Congenital Trochlear Nerve Palsy

Congenital fourth nerve palsy is common and may not become symptomatic until later in life.

Patients may have compensated for the deviation for years with a habitual head tilt.

Old photographs can be very helpful.

A longstanding head tilt away from the affected side in childhood photographs strongly supports a congenital palsy.

Decompensation may occur later because of:

• Aging
• Illness
• Fatigue
• Reduced fusional reserves
• Trauma

Diagnosis

History

Patients usually complain of binocular vertical or diagonal diplopia.

Symptoms are classically worse when:

• Looking downward
• Reading
• Walking downstairs
• Looking down while eating

Some patients describe the image in the affected eye as appearing tilted or rotated.

A characteristic compensatory maneuver is tilting the head away from the affected side, which reduces the vertical separation of the images.

Physical Examination

Superior Oblique Weakness

The affected eye has difficulty depressing when it is adducted.

This is often most apparent when the patient looks:

• Toward the opposite side
• Then downward

The ipsilateral inferior oblique may appear relatively overactive, producing overelevation in adduction.

Hypertropia

The eye affected by a fourth nerve palsy is usually hypertropic.

The hypertropia is generally greatest when:

• Looking toward the opposite side
• Tilting the head toward the affected side

This pattern helps localize the involved superior oblique muscle.

Head Tilt

Patients commonly adopt a compensatory head tilt away from the palsied side.

For example, with a right fourth nerve palsy, the patient may tilt the head to the left.

This reduces diplopia and allows better binocular fusion.

Bielschowsky Head-Tilt Test

The vertical deviation usually increases when the head is tilted toward the side of the palsy.

This occurs because head tilt normally stimulates intorting muscles. In a weak superior oblique, the eye cannot intort properly, and the unopposed elevators produce greater hypertropia.

This is an important component of the classic diagnostic pattern.

Three-Step Test

The traditional Parks–Bielschowsky three-step test can help identify a fourth nerve palsy.

The clinician determines:

1. Which eye is hypertropic in primary gaze
2. In which horizontal gaze the hypertropia increases
3. With which head tilt the hypertropia increases

The resulting pattern can help identify the paretic superior oblique.

However, real-world cases may not always follow the classic pattern perfectly.

Vertical Fusional Amplitude

Patients with congenital trochlear nerve palsy often develop unusually large vertical fusional amplitudes.

A vertical fusional amplitude greater than approximately 3 prism diopters supports a longstanding congenital deviation rather than a newly acquired palsy.

Ptosis

A true isolated fourth nerve palsy does not cause ptosis.

A patient may voluntarily close one eye to eliminate diplopia, but actual levator weakness suggests another diagnosis.

Diagnostic Tests and Interpretation

Laboratory Evaluation

In adults with possible microvascular disease, evaluation may include:

• Blood pressure
• Fasting glucose
• HbA1c
• Lipid profile

If symptoms suggest giant cell arteritis, particularly in an older adult, inflammatory markers and urgent systemic evaluation are indicated.

Imaging

A typical isolated fourth nerve palsy with a clear congenital, traumatic, or microvascular explanation may not always require immediate imaging.

However, neuroimaging should be considered when:

• The palsy is atypical
• Other neurologic findings are present
• There is progressive worsening
• There is no improvement after several months
• A tumor or structural lesion is suspected

MRI is generally preferred for evaluating brainstem, cavernous sinus, and posterior fossa disease.

Differential Diagnosis

Bilateral Fourth Nerve Palsy

Bilateral trochlear palsies are particularly associated with trauma.

Clues include:

• Alternating hypertropia depending on gaze
• Large excyclotorsion
• V-pattern esotropia
• Chin-down posture
• Bilateral superior oblique underaction

Bilateral cases can be more difficult to recognize than unilateral palsy.

Myasthenia Gravis

Ocular myasthenia can mimic almost any ocular motor nerve palsy.

Clues include:

• Variable ptosis
• Fatigability
• Changing alignment
• Diurnal variation
• Inconsistent motility pattern

Pupillary function remains normal.

Thyroid Eye Disease

Graves orbitopathy can produce vertical diplopia from restrictive extraocular muscle disease.

Associated findings may include:

• Lid retraction
• Proptosis
• Conjunctival chemosis
• Restrictive motility
• Abnormal thyroid studies

Restriction of the inferior rectus can especially mimic a superior oblique palsy.

Skew Deviation

Skew deviation is a supranuclear vertical strabismus caused by imbalance in vestibular pathways.

It may occur with:

• Brainstem stroke
• Cerebellar disease
• Other central neurologic disorders

Features favoring skew include:

• Associated neurologic signs
• Ocular torsion pattern inconsistent with fourth nerve palsy
• Reduction of vertical deviation when supine in some cases

Superior Oblique Myokymia

Superior oblique myokymia causes brief, recurrent episodes of:

• Monocular oscillopsia
• Vertical movement
• Torsional movement
• Image tilting

It may result from neurovascular compression of the fourth nerve root exit zone, multiple sclerosis, or rarely posterior fossa lesions.

It differs from trochlear palsy because symptoms are episodic rather than a persistent weakness.

Giant Cell Arteritis

GCA can rarely cause an ocular motor palsy.

In older patients, ask about:

• New headache
• Scalp tenderness
• Jaw claudication
• Weight loss
• Polymyalgia symptoms

If suspected, urgent treatment and systemic evaluation are required.

Treatment

General Measures

Many patients can reduce symptoms by adopting a compensatory head tilt away from the affected side.

This is a natural adaptation and may be sufficient in mild cases.

Prism Glasses

Prisms can be very useful for persistent vertical or diagonal diplopia, particularly when the deviation is relatively small and stable.

Options include:

• Temporary Fresnel prisms
• Ground-in prisms for stable deviations

Prisms are often more successful in fourth nerve palsy than in third nerve palsy because the deviation may be more manageable in primary gaze.

Occlusion

If torsional or vertical diplopia cannot be controlled with prism, temporary occlusion can be used.

Options include:

• Eye patch
• Frosted spectacle lens
• Translucent tape on one lens

This eliminates diplopia but sacrifices binocular vision.

Management of Vascular Risk Factors

In presumed microvascular palsy, optimize:

• Blood pressure
• Blood glucose
• Lipid levels
• Smoking status
• Overall cardiovascular health

Referral

Any persistent, progressive, atypical, or unexplained fourth nerve palsy should undergo formal ophthalmic or neuro-ophthalmic evaluation.

Neurology may be appropriate when associated neurologic signs are present.

Surgical Treatment

Strabismus surgery may be considered when:

• Diplopia persists
• The deviation has become stable
• Prisms do not provide adequate relief
• A significant compensatory head posture remains

Surgery is usually deferred until spontaneous recovery is no longer expected.

For newly acquired palsies, this often means waiting many months, commonly close to a year depending on the etiology and clinical course.

Possible procedures include weakening or strengthening selected extraocular muscles based on the specific deviation pattern.

Ongoing Care

Patients should be monitored for:

• Improvement of diplopia
• Change in hypertropia
• Development of torsional symptoms
• Resolution of compensatory head posture
• Evidence of another neurologic process

Children with congenital palsy should also be assessed for:

• Amblyopia
• Strabismus
• Facial asymmetry from longstanding head tilt

Prognosis

Many patients with microvascular or traumatic fourth nerve palsy experience spontaneous improvement over several months.

Recovery may occur within approximately 3–9 months, although the exact course depends on the cause and severity of injury.

Congenital palsies generally do not recover anatomically but may remain well compensated for long periods.

High-Yield Clinical Pearl

Think of a fourth nerve palsy when a patient has vertical or diagonal diplopia that is worse on downgaze, a hypertropia that increases with head tilt toward the affected side, and a compensatory head tilt away from the palsied side.

Ophthalmology – Isolated Oculomotor Nerve (Cranial Nerve III) Palsy

Basics

Description

The oculomotor nerve, or cranial nerve III, innervates most of the extraocular muscles as well as the levator muscle of the upper eyelid and the parasympathetic fibers controlling pupillary constriction.

It supplies the:

• Levator palpebrae superioris
• Superior rectus
• Medial rectus
• Inferior rectus
• Inferior oblique
• Pupillary constrictor pathway through parasympathetic fibers

A complete third nerve palsy therefore causes a combination of ptosis, ophthalmoplegia, and sometimes pupillary dilation.

Pupillary involvement in a third nerve palsy represents an efferent pupillary abnormality, not a relative afferent pupillary defect.

Alert

A nontraumatic third nerve palsy with ipsilateral pupillary dilation must be considered compressive until proven otherwise.

The most important life-threatening cause is a posterior communicating artery aneurysm.

This requires urgent vascular imaging and neurologic or neurosurgical assessment.

Anatomy and Pathophysiology

The third nerve emerges from the midbrain and travels through the subarachnoid space near the posterior communicating artery before entering the cavernous sinus and orbit.

The parasympathetic pupillary fibers lie relatively superficially along the outside of the nerve.

Because of this arrangement, an external compressive lesion such as an aneurysm can preferentially affect these superficial fibers and produce:

• A dilated pupil
• Poor or absent pupillary light response

By contrast, microvascular ischemic lesions related to diabetes or hypertension tend to affect the deeper central portion of the nerve and may initially spare the superficial pupillary fibers.

This is the basis of the traditional distinction between pupil-involving and pupil-sparing third nerve palsies, although modern evaluation relies heavily on imaging rather than the pupil alone.

Etiology

Important causes include:

• Microvascular ischemia
• Posterior communicating artery aneurysm
• Trauma
• Tumor
• Infiltrative disease
• Inflammation
• Vasculitis
• Infection
• Cavernous sinus disease
• Midbrain lesions

Microvascular palsies are commonly associated with:

• Diabetes mellitus
• Hypertension
• Hyperlipidemia
• Other vascular risk factors

Pediatric Considerations

Third nerve palsy is uncommon in children.

Possible causes include:

• Congenital palsy
• Birth trauma
• Head trauma
• Tumor
• Infection
• Inflammatory disease
• Ophthalmoplegic neuropathy

Aneurysmal third nerve palsy is much less common in children than in adults.

Children, particularly those within the amblyogenic age range, must be monitored closely for amblyopia.

Severe ptosis or persistent ocular misalignment can interfere with visual development.

Pregnancy Considerations

Third nerve palsy is unusual in pregnancy.

Important causes to consider include:

• Pituitary apoplexy
• Gestational diabetes
• Hypertension
• Vascular disease

Pregnant patients with a new neurologic ocular motor deficit require appropriate urgent evaluation.

Diagnosis

History

Patients often complain of binocular diplopia.

The images are commonly separated:

• Horizontally
• Vertically
• Diagonally

Diplopia disappears when either eye is covered.

However, a patient with complete third nerve palsy and severe ptosis may not complain of diplopia because the drooping eyelid occludes the affected eye.

Important historical questions include:

• Sudden versus gradual onset
• Headache
• Periorbital pain
• Trauma
• Diabetes
• Hypertension
• Cancer history
• Inflammatory disease
• Symptoms of giant cell arteritis in older adults
• Other neurologic symptoms

Physical Examination

Complete Third Nerve Palsy

A complete third nerve palsy classically produces:

• Ptosis
• Eye positioned down and out
• Weakness of adduction
• Weakness of elevation
• Weakness of depression
• Possible pupillary dilation

The eye assumes a down-and-out position because the intact lateral rectus and superior oblique remain relatively unopposed.

Ptosis

Ptosis results from weakness of the levator palpebrae superioris.

It may be partial or complete.

Complete ptosis can mask the ocular deviation and may initially reduce the patient’s awareness of diplopia.

Ocular Motility

Because cranial nerve III controls most extraocular muscles, the affected eye typically has impaired:

• Adduction
• Elevation
• Depression

Abduction remains intact because it is controlled by cranial nerve VI.

Intorsion from the superior oblique, supplied by cranial nerve IV, should also be assessed.

Pupil-Sparing Third Nerve Palsy

A truly pupil-sparing third nerve palsy has:

• Normal pupillary size and reactivity
• Significant or complete weakness of third nerve-mediated eye movements
• Ptosis

Traditionally, this pattern suggests a microvascular ischemic mechanism, particularly in an older patient with diabetes or hypertension.

However, pupillary sparing alone should not be considered an absolute guarantee against a compressive lesion.

Pupil-Involving Third Nerve Palsy

A pupil-involving palsy demonstrates:

• Ipsilateral mydriasis
• Poor pupillary constriction
• Third nerve ophthalmoplegia

This pattern is especially concerning for compressive aneurysm, particularly when the onset is acute and accompanied by pain or headache.

Urgent vascular imaging is required.

Aberrant Regeneration

Damaged third nerve fibers may regenerate along abnormal pathways, producing oculomotor synkinesis.

A classic example is lid-gaze synkinesis, in which a ptotic eyelid elevates when the patient:

• Adducts the eye
• Looks downward

Another finding is pupil-gaze synkinesis, in which the pupil constricts abnormally during adduction.

Primary Aberrant Regeneration

Primary aberrant regeneration occurs without a previously documented acute third nerve palsy.

This pattern suggests a chronic compressive lesion, especially within the:

• Cavernous sinus
• Parasellar region

Possible causes include:

• Meningioma
• Aneurysm
• Other slowly growing compressive lesions

Secondary Aberrant Regeneration

Secondary aberrant regeneration occurs during recovery from a known third nerve injury.

It is particularly associated with:

• Trauma
• Compression

It is unusual following a straightforward microvascular ischemic palsy.

Diagnostic Tests and Interpretation

Blood Testing

If diabetes is suspected, appropriate testing includes:

• Blood glucose
• HbA1c

Additional vascular evaluation may include serum lipid testing.

In older patients with symptoms suggestive of giant cell arteritis, obtain inflammatory markers such as:

• ESR
• CRP

Other testing depends on the clinical scenario.

Imaging

Modern evaluation of a new third nerve palsy generally has a low threshold for neurovascular imaging.

Pupil-Involving Third Nerve Palsy

Urgent imaging is required to exclude aneurysm.

Appropriate studies include:

• CT angiography
• MR angiography

MRI of the brain and orbits may also be useful depending on the clinical presentation.

If noninvasive imaging remains inconclusive but clinical suspicion for aneurysm remains high, further vascular assessment may be required.

Persistent Palsy

If a presumed microvascular palsy does not begin to improve within the expected period or remains significantly abnormal after several months, further imaging should be considered.

MRI is useful for excluding:

• Mass lesions
• Infiltrative disease
• Cavernous sinus disease
• Midbrain pathology

Lumbar Puncture

Lumbar puncture may be considered when:

• Imaging is unrevealing
• Infection or inflammation is suspected
• Meningeal disease remains in the differential diagnosis

It is not routinely required for a typical isolated microvascular palsy.

Differential Diagnosis

Myasthenia Gravis

Myasthenia can closely mimic a pupil-sparing partial third nerve palsy.

Features favoring myasthenia include:

• Fluctuating weakness
• Fatigability
• Variable ptosis
• Changing ocular motility pattern
• Normal pupils

An isolated apparent medial rectus weakness should particularly raise concern for alternatives such as:

• Internuclear ophthalmoplegia
• Myasthenia gravis

rather than automatically being labeled a partial third nerve palsy.

Cavernous Sinus Lesion

A cavernous sinus process may affect multiple cranial nerves.

Examine carefully for:

• CN IV dysfunction
• CN VI dysfunction
• Reduced sensation in V1
• Reduced sensation in V2

Multiple cranial neuropathies strongly suggest a cavernous sinus or orbital apex process.

Giant Cell Arteritis

In older adults, giant cell arteritis can occasionally produce ocular motor nerve palsies.

Ask about:

• New headache
• Scalp tenderness
• Jaw claudication
• Weight loss
• Polymyalgia symptoms

Because untreated GCA can cause bilateral irreversible blindness, suspected cases require immediate treatment and systemic evaluation.

Adie Tonic Pupil

If the patient has an isolated dilated pupil but:

• Normal eyelid function
• Normal ocular motility
• No other third nerve findings

then a complete third nerve palsy is unlikely.

A tonic pupil, pharmacologic dilation, or local iris abnormality should be considered.

Treatment

Treatment depends on the underlying cause.

Aneurysmal Third Nerve Palsy

A suspected aneurysmal palsy requires urgent:

• Neurovascular imaging
• Neurology or neurosurgical consultation

Definitive treatment may involve:

• Endovascular coiling
• Surgical clipping
• Other vascular intervention

depending on aneurysm anatomy and clinical circumstances.

Microvascular Third Nerve Palsy

Management focuses on vascular risk-factor control.

Important measures include optimization of:

• Blood pressure
• Blood glucose
• Lipid levels
• Smoking status
• Overall cardiovascular risk

Most isolated microvascular third nerve palsies improve spontaneously.

Giant Cell Arteritis

When GCA is strongly suspected, treatment should begin immediately rather than waiting for definitive confirmation.

High-dose corticosteroid therapy is required, with route determined by visual and systemic findings.

Diplopia Management

Temporary symptomatic options include:

• Occlusion of one eye
• Frosting one spectacle lens
• Temporary patching

Prisms are often of limited benefit early because the deviation is usually highly incomitant, meaning it changes substantially with gaze direction.

Children and Amblyopia

Children in the amblyogenic age range require close monitoring.

Management may include:

• Patching
• Optical correction
• Treatment of strabismic amblyopia
• Management of visual-axis obstruction from ptosis

The goal is to preserve visual development while the neurologic disorder is being treated or observed.

Referral

Urgent neurology or neurosurgical assessment is indicated for:

• Pupil-involving third nerve palsy
• Suspected aneurysm
• Progressive neurologic findings
• Severe headache
• Additional cranial neuropathies

Other referrals may include:

• Primary care
• Endocrinology
• Rheumatology
• Neuro-ophthalmology

depending on the underlying cause.

Follow-Up

A new presumed microvascular pupil-sparing third nerve palsy requires close early observation.

The pupil and ocular motility should be rechecked to ensure that:

• Pupillary involvement does not develop
• No additional neurologic signs appear
• The palsy begins to improve as expected

Historically, daily or very frequent pupil reassessment during the first several days was recommended when immediate imaging was not performed.

Prognosis

The prognosis depends strongly on the etiology.

Microvascular ischemic palsies often show substantial spontaneous improvement over several weeks to months.

Compressive, traumatic, or infiltrative lesions may have incomplete recovery.

Persistent Strabismus

If significant ocular misalignment remains stable long after neurologic recovery, strabismus surgery may be considered.

Surgical rehabilitation is generally more successful in a partial third nerve palsy than in a complete palsy.

Ptosis Surgery

Persistent ptosis may eventually be treated surgically.

However, caution is necessary in patients with:

• Poor Bell phenomenon
• Significant ophthalmoplegia
• Reduced corneal sensation

because lifting the eyelid can produce serious exposure keratopathy.

In severe complete palsy, frontalis suspension or other reconstructive procedures may provide cosmetic and functional improvement, but normal ocular motility is unlikely to be restored.

Complications

The most important complication is failure to recognize a posterior communicating artery aneurysm, which can be life-threatening.

Other complications include:

• Persistent diplopia
• Chronic strabismus
• Persistent ptosis
• Aberrant regeneration
• Exposure keratopathy after ptosis repair
• Amblyopia in children
• Permanent neurologic deficits

Unrecognized giant cell arteritis can result in catastrophic bilateral visual loss.

The key clinical principle is: an acute third nerve palsy with pupillary involvement requires urgent exclusion of a compressive aneurysm, while an apparently microvascular palsy still requires careful clinical assessment and follow-up.